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Abstract 
 
Characterization of Proteins and Peptides via Enhanced 266 nm 
Ultraviolet Photodissociation Mass Spectrometry utilizing a Selenium 
Based Chromophore 
 
William Ryan Parker, M.A. 
The University of Texas at Austin, 2016 
 
Supervisor:  Jennifer S. Brodbelt 
 
Mass spectrometry and chemical derivatization have been used as tools for the 
identification of proteins in both top-down and bottom-up studies.  Cysteine is the rarest 
and most nucleophilic amino acid thus making it a popular target for chemical tagging 
strategies.  Ultraviolet photodissociation (UVPD) is a versatile activation technique for 
fragmentation of peptides and proteins.  For successful photodissociation, ions of interest 
must contain a suitable chromophore that matches the wavelength of irradiation.   N-
(Phenylseleno)phthalimide (NPSP) is a fast reacting reagent which attaches a selenium 
based chromophore that absorbs at 266 nm light to free thiols.  In the studies presented in 
this thesis, NPSP was used to derivatize free cysteine residues in both intact proteins and 
tryptic peptides.  Activation with 266 nm photons causes a dominant neutral loss of the 
benzeneselenol groups on the tagged protein or peptide ions.  This diagnostic neutral loss 
allows the determination of the number of free versus bound cysteine residues in intact 
proteins.  Additionally, tagging peptides with benzeneselenol provides a means to target 
 vi 
only the cysteine-containing peptides in bottom-up proteomics experiments.  Both of 
these methods provide a significantly reduced search space for identification of cysteine-
containing proteins.  Counting the number of cysteine residues also provides an effective 
way to restrict the number of protein candidates for database searches.  Moreover, 
cysteine peptides are inherently more unique than other peptides created upon enzymatic 
digestion of proteins due to the low frequency of cysteine in the proteome, thus allowing 
these peptides to be used as surrogates for protein identification.    
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Chapter One: Characterization of the Cysteine Content in Proteins 
utilizing Cysteine Selenylation with 266 nm Ultraviolet 
Photodissociation (UVPD)1 
OUTLINE 1.1 
Characterization of the cysteine content of proteins is a key aspect of proteomics. 
By defining both the total number of cysteines and their bound/unbound state, the number 
of candidate proteins considered in database searches is significantly constrained. Herein 
we present a methodology that utilizes 266 nm UVPD to count the number of free and 
bound cysteines in intact proteins. In order to attain this goal, proteins were derivatized 
with N-(phenylseleno)phthalimide (NPSP) to install a selectively cleavable Se-S bond 
upon 266 UVPD. The number of Se-S bonds cleaved upon UVPD, a process that releases 
SePh moieties, corresponds to the number of cysteine residues per protein.    
INTRODUCTION 1.2 
Cysteine is involved in both stabilizing tertiary protein structure through disulfide 
bonding and modulation of protein redox activity [1]. There have been numerous studies 
aimed at characterization of the redox states of cysteines in proteins owing to the inherent 
importance of cysteine-mediated chemistry in countless biological processes. Methods such 
as UV absorption spectroscopy [2], fluorescent labeling [3], and X-ray absorption 
spectroscopy [4] have been used to quantify or characterize the cysteine content of proteins.  
Characterizing cysteine content by mass spectrometry (MS) has also become a popular 
option as a consequence of the development of well-established bottom-up proteomics 
approaches [5–7] often in combination with various clever cysteine-selective derivatization 
                                                 
1 Parker, W.R., Brodbelt, J.S.: Characterization of the Cysteine Content in Proteins Utilizing Cysteine 
Selenylation with 266 nm Ultraviolet Photodissociation (UVPD). J. Am. Soc. Mass Spectrom. ASAP 
(2016).  Co-author Jennifer Brodbelt provided research funding. 
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methods [8].  MS strategies for determination of cysteines  have been based on the 
utilization of mass tags [9] or isotopic labels [10, 11], differential monitoring of ESI mass 
spectra after cysteine-selective reactions [12], proteolysis in isotopically heavy solvents 
[13], characterization by high resolution top down MS/MS [14], or utilization of selective 
ion/ion reactions [15, 16], all of which have proven to be versatile methods for either 
qualitative or quantitative characterization of cysteine content of proteins and peptides.  
Electrochemical tagging reactions of cysteines have also been implemented via coupling an 
electrochemical cell in an on-line fashion to a mass spectrometer [17–21]. The latter 
methodologies have even shown promise for mapping reactivities of cysteine residues in 
different locations of proteins [22].  Chemical derivatization of cysteine residues in peptides 
and proteins by reactions with quinone has been shown to differentiate free thiols versus 
disulfide bonds [23].  For this prior study, 266 nm UVPD was used to promote homolytic 
cleavage of C-S bonds of quinone-derivatized proteins and peptides, generating neutral loss 
products which were subjected to CID to achieve radical-directed dissociation (RDD) [23].  
Selective cleavage of disulfide bonds to elucidate disulfide-linked peptide pairs has also 
been shown to be effective using 266 nm photodissociation [24].   
N-(phenylseleno)phthalmide (NPSP) is a well-known selenylating reagent [25, 26].  
Fast, efficient, and selective selenylation of cysteine-containing species has been achieved 
previously using NPSP (Scheme 1.1)  [27–29].  Additionally, on-line electrolytic cleavage 
of disulfides via an electrochemical cell  prior to reactions with NPSP and MS analysis has 
been reported as a means to identify disulfide-containing peptides in digests [30].  Herein 
we present a strategy for counting cysteine residues in proteins based on NPSP-based 
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selenylation followed by 266 nm UVPD to selectively and exclusively cleave the tags.  The 
cysteine content information can be utilized in conjunction with informatics engines such as 
UniProt to generate a list of candidate proteins from a proteome that match the cysteine 
content observed experimentally. 
 
Scheme 1.1: Scheme showing reaction of N-(phenylseleno)phthalimide (NPSP) with a 
free thiol 
METHODS 1.3 
Sample Preparation 
Proteins containing up to eight cysteines were analyzed in three ways: (i) as intact 
proteins prior to NPSP derivatization, (ii) after derivatization with NPSP without 
reduction of intrinsic disulfide bonds, and (iii) after derivatization with NPSP and 
reduction of disulfide bonds.  For both (i) and (ii) proteins were suspended at a 
concentration of 10 μM in 50:50 H2O:acetonitrile and 1% formic acid.  For (ii) the 
proteins were reacted with 10 mM NPSP dissolved in dry acetonitrile (typically using 
200 uL of protein solution and 2 uL of NPSP solution) for 30 seconds prior to analysis by 
mass spectrometry (without clean-up).  For (iii) proteins were reduced by incubation with 
10 mM DTT in 150 mM NH4HCO3 for three hours at 55oC (typically using 200 ul of 
protein solution and 2 uL of DTT solution). Following reduction, proteins were buffer-
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exchanged three times into 1% formic acid using Amicon Ultra Centrifugal Filters 
(Merck Millipore).  Proteins were then diluted by addition of one volume 1% formic acid 
in acetonitrile and incubated with 10 mM NPSP for 30 seconds.  The final protein 
solutions were analyzed without further clean-up. 
Mass Spectrometry 
Mass spectrometry experiments were undertaken in positive ion mode on a 
Thermo Scientific Velos Pro dual-pressure linear ion trap mass spectrometer (San Jose, 
CA) equipped with CID, HCD, ETD, and 266 nm UVPD capabilities.  Each spectrum 
consisted of 3 μscans averaged.  The applied ESI spray voltage was 3 kV.  Tandem mass 
spectrometry was carried out in the high pressure trap for all activation strategies using 
the most abundant ion of the charge state envelope.  For CID and HCD a normalized 
collision energy of 35 NCE was used (during an activation period of 10 ms for CID and 2 
ms for HCD), while for ETD a reaction time from 40-120 ms was utilized.  UVPD was 
implemented in a manner described previously [31] and was performed using the fourth 
harmonic of a Continuum Minilite Nd:YAG laser (San Jose, CA) with an energy output 
of approximately 6 mJ per pulse.  Ions were subjected to an increasing number of 266 nm 
laser pulses until either the precursor was completely eliminated or no additional neutral 
losses were observed.  Post-acquisition, data analysis was assisted by charge state 
deconvolution software, MagTran [32].  Bovine β-lactoglobulin, bovine α-lactalbumin, 
chicken lysozyme, bovine ribonuclease A., bovine aprotinin, horse cytochrome C, and 
bovine serum albumin (BSA) were used in this study. 
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RESULTS AND DISCUSSION 1.4 
ESI-MS Analysis 
Derivatization of each cysteine residue with NPSP results in a mass shift of 156 
Da by the addition of a SeC6H5 moiety through formation of a S-Se bond as depicted in 
Scheme 1.1.  Cysteine sites can be counted in several ways using this reactive tag.  First, 
the net mass shift of a protein is readily observed in the MS1 mass spectrum.  In Figure 
1.1 this is observed for the β-lactoglobulin variants A and B.  Upon deconvolution of the 
charge state envelope, an average molecular weight was determined.  Compared to the 
underivatized proteins in Figure 1.1a, the ones in Figure 1.1b showed a mass shift of 
approximately 155 Da per protein, indicative of one reactive site (one free cysteine) for 
both A and B variants of β-lactoglobulin.  When reduction was performed prior to 
derivatization of the proteins (Figure 1.1c), a more prominent mass addition was 
observed along with a shift to higher charge states.  The shift to higher charge states was 
indicative of the cleavage of disulfide bonds that facilitated more extensive protonation of 
the protein.  The net mass shift observed in Figure 1.1c for reduced β-lactoglobulin was 
781 Da, corresponding to addition of five SePh tags.  From these observations, it is 
deduced that there are five cysteine residues of which four are inaccessible until after 
reduction.   
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Figure 1.1. β-lactoglobulin A (blue) and B (red) for (a) unmodified, (b) NPSP-modified, 
and (c) NPSP-modified after reduction.  (# = + 5 SePh, * = + SePh) 
The same strategy was used for lysozyme (Figure 1.2), ribonuclease A (Figure 1.3), 
aprotinin (Figure 1.4), α-lactalbumin (Figure 1.5), cytochrome C (Figure 1.6) and BSA 
(Figure 1.7), and the findings are summarized in Table 1.1.   In each case the number of 
free cysteines and disulfides was correctly deduced based on monitoring the mass shifts 
upon reaction with NPSP prior to or after reduction of the protein.  Ribonuclease A and 
aprotinin exhibited no reactions with NPSP prior to reduction, indicating the absence of free 
cysteines.  After reduction and reaction with NPSP, ribonuclease A displayed a mass shift 
consistent with addition of eight SePh tags; for aprotinin it was addition of six SePh tags.  
For both ribonuclease A (Figures 1.3a, 1.3b) and aprotinin (Figures 1.4a, 1.4b), a +98 Da 
mass addition to the intact protein was observed in the mass spectra prior to NPSP reactions. 
 7 
This adduct was attributed to non-covalently bound sulfuric or phosphoric acid which is 
known to interact strongly with surface accessible basic sites of the protein [31].  This 
adduct was easily dislodged in the cleanup step performed on each protein after reduction 
and prior to selenylation (Figures 1.3c, 1.4c) and did not impede the NPSP tagging strategy.  
For aprotonin, the smallest protein used in this study, a distinct broadening of the peaks in 
the charge envelope was observed in Figure 1.4c.  This was due to the broad isotopic 
distribution of the selenium component of the tag and was not especially noticeable for the 
larger proteins due to their significantly higher charge states (and thus more compressed 
peak widths). 
 
Figure 1.2. ESI mass spectra of lysozyme: (a) unmodified, (b) NPSP-modified prior to 
reduction, and (c) NPSP-modified after reduction 
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Figure 1.3:  ESI mass spectra of ribonuclease A:  (a) unmodified, (b) NPSP-modified 
prior to reduction, and (c) NPSP-modified after reduction. Ions containing 
contaminating adduct (~98 Da) for ribonuclease A are denoted by a solid 
red circle. (* = SePh, # = 8 SePh) 
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Figure 1.4. ESI mass spectra of aprotinin:  (a) unmodified, (b) NPSP-modified prior to 
reduction, and (c) NPSP-modified after reduction. Ions containing 
contaminating adduct (~+98 Da) aprotinin are denoted by a solid red circle. 
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Figure 1.5. ESI mass spectra of α-lactalbumin:  (a) unmodified, (b) NPSP-modified prior 
to reduction, and (c) NPSP-modified after reduction. 
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Figure 1.6. ESI mass spectra of cytochrome c:  (a) unmodified, (b) NPSP-modified prior 
to reduction, and (c) NPSP-modified after reduction 
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Figure 1.7. ESI mass spectra of BSA:  (a) unmodified and (b) NPSP-modified prior to 
reduction 
The NPSP tagging method indicated that alpha-lactalbumin had four disulfide-bound 
cysteines and no free cysteines and that cytochrome c had two disulfide-bound cysteines and 
no free cysteines (Table 1.1).  The NPSP strategy was unsuccessful for characterization of 
BSA due to incomplete tagging, an outcome not unexpected owing to the fact that BSA has 
35 cysteines. The method showed mixed success for lysozyme. Lysozyme has eight 
cysteines, all engaged in disulfide bonds. Upon reaction with NPSP, the resulting mass 
spectrum displayed a mass shift corresponding to attachment of one SePh tag which 
suggested the presence of one free cysteine. This odd result may correspond to partial 
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degradation of lysozyme, thus leading to cleavage of one disulfide bond in the intact protein. 
Although addition of two SePh tags might be expected for this scenario, it is possible that 
one cysteine remains inaccessible owing to the six other disulfide bonds in the protein. 
Upon reduction of lysozyme and reaction with NPSP, the resulting mass shift was consistent 
with eight cysteines as expected.   
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Table 1.1: Comparison of theoretical and experimental cysteine counting results.  All 
calculations are done based on the chain region of the protein as defined by 
UniProt.  The percent proteome match signifies the percentages of proteins 
in each proteome which have the same cysteine content (free vs bound 
cysteines) as the protein listed in that row.  The percent proteome match was 
calculated using a custom python script.  
Protein 
(AC) 
[Species] 
Free cys 
(Uniprot) 
Free cys 
(exp) 
Total 
cys 
(Uniprot) 
Total cys 
(exp) 
Figures % 
Proteome 
Match 
β-lactoglobulin 
(P02754) 
[Bos taurus] 
1 1 5 5 1.1,  
1.8 
0.11%  
(28 out of 
24113) 
Lysozyme 
(P00698) 
[Gallus gallus] 
0 1 8 8 1.2,  
1.9 
0.03%  
(6 out of 
17691) 
ribonuclease A 
(P61823) 
[Bos taurus] 
0 0 8 8 by mass 
7 by UVPD 
1.3, 
 1.10 
0.15% 
 (36 out of 
24113) 
Aprotinin 
(P00974) 
[Bos taurus] 
0 0 6 6 1.4,  
1.11, 
1.15 
0.31%  
(74 out of 
24113) 
α-lactalbumin 
(P00711) 
[Bos taurus] 
0 0 8 8 1.5,  
1.12 
0.15%  
(36 out of  
24113) 
cytochrome C 
(P00004) 
[Equus 
caballus] 
0 0 2 2 1.6,  
1.13, 
1.16 
0.08%  
(19 out of 
22718) 
BSA
1 
(P02769) 
[Bos taurus] 
1 1 35 N/A 1.7,  
1.14 
< 0.01%  
(2 out of 
24113) 
1Only the oxidized form of BSA was evaluated because it has only one free cysteine out of 35 
total cysteines;  the products formed after reduction of BSA would not be resolvable.    
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Analysis by 266 nm UVPD 
Sulfur-selenium bonds have been shown previously to be photolytically cleavable in 
solution, producing radical products [32].  Implementation of this type of photoreaction for 
ions in the gas phase using 266 nm photons in the present study resulted in exclusive 
cleavage of the S-Se bonds and loss of the SePh tags.  Monitoring the loss of SePh tags was 
used as a second facile means to count the number of cysteine residues per protein (i) prior 
to reduction and (ii) post-reduction.   
Examples of the mass spectra obtained upon UVPD of the SePh-tagged proteins are 
shown in Figure 1.8 for beta-lactoglobulin A and B.  Irradiation of unmodified β-
lactoglobulin with 266 nm photons (2 laser pulses, 6 mJ) resulted in no significant 
dissociation, as shown in  Figures 1.8a and 1.8b for the A and B forms of the protein (15+ 
charge state), respectively.  However, the SePh-modified proteins (Figure 1.8c-f), 
dissociated by loss of one SePh tag for the non-reduced proteins or by loss of five SePh tags 
for the reduced proteins upon 266 nm UVPD (2 laser pulses, 6 mJ).   Cleavage of the S-Se 
bonds is both extremely efficient and highly selective upon absorption of 266 nm photons, 
yielding a neutral loss of 156 Da per cleaved tag.  For both variants of β-lactoglobulin, 266 
nm UVPD indicated one free and four bound cysteine residues.  This UVPD method was 
extended to lysozyme (Figure 1.9), ribonuclease A (Figure 1.10), aprotinin (Figure 1.11), 
α-lactalbumin (Figure 1.12), cytochrome C (Figure 1.13), and BSA (Figure 1.14).  Using 
multiple laser pulses facilitated removal of the SePh tags as shown for α-lactalbumin in 
Figure 1.12.  The results of the UVPD strategy for counting free and bound cysteines are 
summarized in Table 1.1.   
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Figure 1.8. β-lactoglobulin A (blue) and B (red) activated by 2 laser pulses (266 nm) as 
follows (a,b) unmodified, (c,d) modified with NPSP without reduction, and 
(e,f)  modified with NPSP after reduction.  (* denotes 1 SePh group, # 
denotes 5 SePh groups) 
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Figure 1.9. 266 nm UVPD mass spectra of lysozyme for (a) unmodified (9+), (b) NPSP-
modified before reduction (9+), and (c) NPSP-modified after reduction 
(15+).  (* = SePh, # = 8 SePh) 
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Figure 1.10. 266 nm UVPD mass spectra of ribonuclease A for (a) unmodified (9+) and 
(b) NPSP-modified after reduction (15+) 
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Figure 1.11. 266 nm UVPD mass spectra of aprotinin for (a) unmodified (7+) and (b) 
NPSP-modified after reduction (6+). (* = 1 SePh, # = 6 SePh) 
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Figure 1.12. UVPD mass spectra of α-lactalbumin for (a) unmodified (8+), and for 
NPSP-modified after reduction (14+) using (b) 1 pulse, (c) 2 pulses, and  (d) 
3 pulses. 
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Figure 1.13. UVPD mass spectra of cytochrome c for (a) unmodified (16+) using 2 
pulses, and for NPSP-modified cytochrome c after reduction (15+) using (b) 
1 pulse, (c) 2 pulses, and  (d) 3 pulses. 
 
 22 
 
Figure 1.14. Isolation of the (a) 50+ and (c) 50+* charge states of BSA and 266 nm 
UVPD (5 laser pulses) of the (b) 50+ and (d) 50+* species. 
Among the proteins examined, ribonuclease A yielded discrepancies in the 
characterization of cysteine content via the UVPD method compared to the result 
obtained from the mass shift observed in the mass spectrum. For ribonuclease A, only 
seven neutral losses were observed with high confidence upon UVPD (Figure 1.10b), 
whereas the NPSP-modified protein contains eight tags and is thus expected to lose eight 
tags.  One hypothesis to explain the fact that only seven out of eight Se-S bonds were 
cleaved in ribonuclease A is that the presence of the aromatic amino acids tyrosine, 
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tryptophan and phenylalanine, all absorb 266 nm photons (with tryptophan and tyrosine 
having significantly larger photoabsorption cross-sections than phenylalanine and thus 
absorbing better). Consider the comparison of 266 nm UVPD spectra for NPSP-tagged β-
lactoglobulin, lysozyme, ribonuclease A, and α-lactalbumin (Figures 1.9, 1.10, 1.12). 
Each of these proteins has a number of aromatic residues 
(tryptophan/tyrosine/phenylalanine) that may absorb 266 nm photons:  2/4/4 (β-
lactoglobulin), 6/3/3 (lysozyme), 0/6/3 (ribonuclease A), and 4/4/4 (α-lactalbumin) for 
tryptophan/tyrosine/phenylalanine residues. Based on absorbance profiles of amino acids 
in solution, it is anticipated that the photoabsorption cross-section for tryptophan in the 
gas phase is likely greater than that of tyrosine at 266 nm, and the photoabsorption cross-
section for phenylalanine is expected to be rather low at 266 nm (these remarks are 
derived from solution profiles, not the gas phase [35]). Excitation energy transfer has 
been shown to occur between tryptophan or tyrosine and disulfide bonds, ultimately 
resulting in homolytic cleavage of the disulfide bond via an excited state [36]. We 
speculate that a similar phenomenon may occur for the NPSP-tagged proteins. For 
example, lysozyme and α-lactalbumin contain multiple tryptophan residues which may 
enhance S-Se bond cleavage from an excited state induced by absorption of 266 nm 
photons (similar to that shown for disulfide bonds [33]). The lack of tryptophan residues 
in ribonuclease A may explain the inhibition of tag loss for the protein. Additionally, 
lysozyme appears to have a less efficient SePh tag loss series than α-lactalbumin, yet both 
proteins contain the same number of cysteine residues. Lysozyme has six tryptophans in 
its primary sequence compared to α-lactalbumin which has only four tryptophans, and 
this may contribute to a greater absorption cross-section for lysozyme and may lead to 
fragmentation by other pathways. While our results indicate that the photoabsorption 
cross-section of the benzeneselenol group is significantly greater than that of the aromatic 
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side-chains at 266 nm, the availability of other absorbing moieties may inhibit S-Se 
cleavage by affording access to other fragmentation pathways, specifically pathways 
caused upon photoabsorption by the aromatic side-chains.  The availability of other 
fragmentation pathways for lysozyme was further supported by activation of non-reduced 
SePh-tagged lysozyme (Figure 1.9b).  For this protein, in addition to the characteristic 
SePh loss, an unexpected loss of 76 Da was also observed suggesting an alternative 
fragmentation route. 
Other Activation Methods (HCD, ETD, CID) 
It was previously reported that NPSP-derivatized peptides undergo Se-S cleavage 
upon ETD or CID [28].  Thus, for comparative purposes collision-based (CID and HCD) 
and electron-based (ETD) methods were also used to activate the SePh-tagged proteins in 
the present study.  Examples of the resulting MS/MS spectra are shown in Figures 1.15 for 
aprotinin (with six SePh tags) and Figure 1.16 for cytochrome C (with two SePh tags).  
Neither HCD nor CID nor ETD resulted in efficient Se-S cleavage. ETD promoted cleavage 
of up to two S-Se cleavages in conjunction with charge reduction for tagged aprotinin; the 
analogous MS/MS spectra for cytochrome c were not readily interpretable.  Based on this 
comparison, 266 nm UVPD showed remarkably high efficiency and selectivity for Se-S 
cleavage relative to the other activation methods. 
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Figure 1.15. Activation of NPSP-modified aprotinin (6+) via (a) HCD (NCE 35), (b) 
CID (NCE 35), and ETD with an activation time of (c) 40 ms and (d) 100 
ms. 
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Figure 1.16: Activation of NPSP-modified cytochrome c (15+) via (a) HCD (NCE 35), 
(b) CID (NCE 35), and ETD with an activation time of (c) 40 ms and (d) 
100 ms. 
CONCLUSION 1.5 
The NPSP-derivatization strategy and 266 nm UVPD proved successful as a new 
means to count free and bound cysteines in proteins. Proteins containing up to eight cysteine 
residues were successfully characterized.  The SePh tag served as an excellent chromophore 
for absorption of 266 nm photons, and the selective cleavage of the Se-S bond was striking.  
Tracking free and bound cysteines has numerous applications in proteomics and offers 
opportunities for incorporation in informatics engines.  For example, the last column of 
Table 1.1 shows the percentages of proteins in each proteome which have the same cysteine 
content (free versus bound cysteines) as each protein included in this study.  On average 
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about 0.1% of all possible proteins match each combination of free and bound cysteines, 
thus illustrating that characterizing cysteine content offers a significant way to constrain 
protein identification in database searches.    
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Chapter Two: Cysteine-Selective Peptide Identification: Selenium-
Based Chromophore for Selective S-Se Bond Cleavage with 266 nm 
Ultraviolet Photodissociation (UVPD) 
OUTLINE 2.1 
 The tremendous number of peptides identified in current bottom-up mass 
spectrometric workflows, although impressive for high throughput proteomics, results in 
little selectivity for more targeted applications.  We describe a strategy for cysteine-
selective proteomics based on a tagging method that installs a S-Se bond in peptides that 
is cleavable upon 266 nm ultraviolet photodissociation (UVPD). The alkylating reagent, 
N-(phenylseleno)phthalimide (NPSP), reacts with free thiols in cysteine residues and 
attaches a chromogenic benzeneselenol (SePh) group.  Upon irradiation of tagged 
peptides with 266 nm photons, the S-Se bond is selectively cleaved, releasing a 
benzeneselenol moiety corresponding to a neutral loss of 156 Da per cysteine.  Herein we 
showcase a new MS/MS scan mode, UVPDnLossCID, which facilitates selective 
screening of cysteine-containing peptides.  A “prescreening” event occurs by activation 
of the top N peptide ions by 266 nm UVPD.  Peptides exhibiting a neutral loss 
corresponding one or more SePh groups are reactivated and sequenced by CID.  Because 
of the low frequency of cysteine in the proteome, unique cysteine-containing peptides 
may serve as surrogates for entire proteins.  UVPDnLossCID does not generate as many 
PSMs as conventional bottom-up methods, however UVPDnLossCID provides far 
greater selectivity. 
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INTRODUCTION 2.2 
Recent advances in bottom-up proteomics strategies have led to unsurpassed 
numbers of peptide and protein identifications from complex cell lysates [34, 35].  In a 
typical bottom-up proteomic workflow, proteins are subjected to proteolytic digestion, 
and the resulting peptides are separated chromatographically prior to ionization and 
identification by tandem mass spectrometry (MS/MS).  Collision induced dissociation 
(CID) [36], including the higher-energy beam type method termed HCD [37], and 
electron-transfer dissociation (ETD) [38, 39] are the most popular methods for activation 
and fragmentation of peptides, and numerous database search methods have been adapted 
for the resulting MS/MS spectra to facilitate identification of the peptides and assignment 
of their parent proteins. Currently it is possible to identify over ten thousand peptides in a 
standard LC-MS/MS run routinely, corresponding to thousands of proteins [40].  
Ultraviolet photodissociation (UVPD) is a more recent activation technique that has 
gained traction and has been applied to a broad range of proteomics applications [41–48].  
In particular, UVPD using 193 nm photons generates very rich fragmentation patterns 
[43, 48], providing high sequence coverage of peptides. 
Despite the impressive level of performance obtained by bottom-up proteomics 
approaches, there remain a number of challenges.  Several obstacles are related to the 
concept of selectivity, either in terms of streamlining the massive LC-MS/MS datasets to 
focus on specific proteins or features of interest, or with respect to redundancies or 
ambiguities in the thousands of spectra obtained in each run.  For example, one issue 
encountered in bottom-up proteomics approaches arises from the presence of 
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confounding peptides, meaning peptides that are characteristic of more than one protein 
[49].  These ambiguous peptides occur when two or more proteins yield the same 
proteolytic product.  A related problem occurs upon MS/MS analysis of co-eluting 
peptides, particularly ones that generate ions with overlapping m/z values [50, 51].  The 
resulting fragmentation patterns which contain product ions from more than one peptide 
are referred to as chimera spectra and increase false negative identifications by up to 
twofold by diluting search scores for true positive assignments [52].  Strategies to resolve 
these issues have employed database filtering prior to the search to incorporate only 
unique peptides [53–55].  This workaround has shown to lower statistical q-values (not to 
be confused with ion trap Mathieu stability) by reducing the search space, thus increasing 
peptide confidence [55–58].  Building selectivity into a proteomic workflow to allow 
meaningful database filtering to include only those peptides that contain a more specific 
type of amino acid composition have shown similar types of improvement [58, 59]. 
Another rationale for building selectivity into bottom-up workflows is to allow 
enhanced sampling for peptides of interest.  Typical data-dependent acquisitions are set 
up to fragment the top N most abundant ions as the peptides elute from the column [60].  
Dynamic exclusion settings prevent re-activation of the most abundant ions in each 
subsequent spectrum, thus facilitating the analysis of less abundant ions [61].  However, 
as sample complexity increases it becomes more probable that many peptides will elute 
simultaneously. Thus, normal dynamic exclusion parameters may overlook less abundant 
ions, masking features of special interest. Employing selective enrichment methods using 
an affinity tag or a residue selective resin offers one solution to this problem [62, 63].  
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Typically the enrichment methods remove a large portion of peptides from a sample, thus 
enhancing the detection of the remaining peptides while simultaneously alleviating the 
production of MS/MS spectra that contain fragment ions from multiple peptides [64].  
Enrichment procedures can be somewhat time-consuming and thus are not always 
feasible or efficient depending on the aim of the proteomics application. Therefore, a 
similar outcome can be accomplished alternatively by using a method that essentially 
ignores ions not exhibiting a unique characteristic, such as a neutral loss or isotope 
pattern [65–67]. 
Another strategy for incorporating a higher degree of selectivity into a proteomics 
workflow exploits the use of specific chromophores and UVPD [59, 68–70].  In this case, 
only peptides that are tagged with the chromophore absorb photons, are activated, and 
undergo dissociation.  This concept can yield a highly selective and targeted approach 
depending on how the chromophore tags are incorporated, for example via derivatization 
of a particular amino acid side-chain.  The combination of derivatization and UVPD 
affords a tunable way to streamline the search methods used for peptide identification and 
can increase the probability of analyzing low abundance peptides.  For example, standard 
tryptic peptides do not absorb photons in the range of 350 nm. Derivatization of the 
peptides to attach suitable chromophores has been used to convert non-absorbing 
peptides to highly chromogenic peptides that undergo efficient photodissociation when 
exposed to 351 nm photons (from an excimer laser) [58, 68, 70].  This concept has been 
used to target peptides containing histidine or tyrosine via a diazonium reaction [58], as 
well as cysteine-containing peptides to allow selective analysis of the antigen-binding 
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regions of antibodies [70].  A similar UVPD method was used to map solvent 
accessibility of proteins based on analysis of peptides tagged with a chromogenic 
chemical probe [68].  Strategies using photodissociation at 473 nm have also shown great 
promise for selective fragmentation of cysteine-containing through cysteinyl alkylation 
with a Dabcyl group [69].  This strategy has been employed as a photo-selected reaction 
monitoring (photo-SRM, employing 473 nm photodissociation) experiment and has 
shown to be as sensitive as conventional SRM experiments for complex human serum 
samples [71].  There have also been a number of reports showing selective bond 
cleavages of peptides derivatized with quinone or napththalenethiol tags (among others) 
upon UVPD at 266 nm, the latter via a type of radical directed dissociation [23, 24, 72–
75].   
In the present study, we report a strategy that uses 266 nm UVPD to target 
cysteine-containing peptides via tagging with N-(phenylseleno)phthalimide (NPSP) [25, 
26] (see Scheme 2.1).  NPSP is a class of benzeneselenyl radical precursors which have 
shown to be photo-labile under ultraviolet radiation [32].  Numerous chemical probe 
strategies have been developed that target specific amino acids in order to map topologies 
of proteins, to evaluate protein interactions, and to streamline the identification of 
primary sequences [8, 76–78].  Development of methods to focus on cysteine residues 
offers a particularly compelling opportunity for enhanced selectivity for bottom-up 
proteomics. Cysteine (Cys) is the only amino acid that contains a sulfhydryl moiety, thus 
making it one of the most nucleophilic and reactive amino acids [78].  Cysteine is also 
one of the rarest amino acids in the proteome; however, due to its importance in 
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stabilizing protein structure through disulfide bonds and modulating redox-based 
reactions in-vivo, the residue is present in almost all proteins thus making it an ideal 
candidate for targeted applications.  In fact, it is estimated that 97% of the proteins in the 
human proteome contain at least one cysteine [8].  Furthermore, since peptides containing 
cysteine are likely to be unique, building a targeted cysteine method allows the potential 
of whole-protein identification based on surrogate peptides at higher levels of confidence. 
NPSP has been shown previously to yield fast and efficient derivatization of free cysteine 
residues [27–30].  Other methods for detecting cysteine-containing residues based on 
mass shifts due to the loss of different hydroquinone derivatives have also been explored 
and shown to increase protein scores when incorporated into MASCOT database 
searches, demonstrating the advantages of selectivity in HPLC-MS/MS workflows [20, 
22]. 
 
Scheme 2.1. Reaction of free thiols with N-(phenylseleno)phthalimide. 
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METHODS 2.3 
Materials and Reagents 
N-(Phenylseleno)phthalimide and all proteins were obtained from the Sigma-
Aldrich company.  High purity water, acetonitrile, and formic acid were obtained from 
ThermoFisher Scientific.  Molecular weight cutoff filters were obtained from Pierce. 
Chemical Modification and Preparation 
Single proteins were digested by trypsin in a ratio of 1:50 protease:protein for 6 
hours at 37oC.  Protein mixtures of horse cytochrome C and myoglobin and bovine α-
lactalbumin, bovine β-lactoglobulin A/B, bovine carbonic anhydrase II, bovine fetuin B, and 
bovine serum albumin (BSA) were digested in a 1:20 protease:protein ratio for 18 hours at 
37oC.  Following digestion, samples were subjected to reduction with 5 mM DTT at 55oC 
for 1 hour.  Samples were desalted using Pierce C18 spin column and then reconstituted in 
50/50/1 acetonitrile/water/formic acid and reacted for 30 seconds with a 10 molar excess of 
N-(phenylseleno)phthalimide (NPSP)  per cysteine residue (Scheme 2.1).  An addition of 
1% formic acid was added to all solvents used in the C18 cleanup to prevent disulfide bonds 
from reformation.  Because selenylsulfide (Se-S) and disulfide bonds (S-S) have similar 
reduction potentials, the NPSP alkylation reaction could not be undertaken in the presence 
of reducing reagents such as dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP). 
In order to achieve successful derivatization of disulfide-containing peptides, a buffer 
exchange step into formic acid following reduction was implemented.   
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Chromatography and Mass Spectrometry 
CID, HCD, and UVPDnLossCID were carried out on a Velos Pro dual linear ion trap 
mass spectrometer (Thermo Scientific, San Jose, CA) equipped with a Continuum frequency 
quadrupled Nd:YAG laser (266 nm) in a manner similar to that described previously [79].  
ETD experiments were performed on a LTQ XL linear ion trap mass spectrometer (Thermo 
Scientific, San Jose, CA).  LCMS was performed using a Dionex 3500RSC nanoLC system.  
The trap and analytical columns were packed in-house with Michrom Magic C18 packing 
material with inner diameters of 150 and 75 μm, respectively.  Solvent A was composed of 
0.1% formic acid in water, and solvent B had a composition of 0.1% formic acid in 
acetonitrile.  Approximately 250 ng (1 µL of a 250 ng/µL digestion) of single protein digests 
and 500 ng of protein mixture digestions were loaded and separated using a gradient from 
2% to 35% B over 75 minutes at a flow rate of 300 nL/min. Dynamic exclusion parameters 
had a repeat and exclusion duration of 30 seconds with an exclusion list size of 500 and 
repeat count of 1.  For CID, HCD and ETD experiments, the ten most abundant ions in each 
MS1 scan were activated using an NCE of 35 for HCD and CID.  The activation times of 
ETD and CID were 100 ms and 10 ms, respectively.  A new scan mode termed 
UVPDnLossCID was developed in the data-dependent acquisition code. For 
UVPDnLossCID the top five most abundant peaks were activated by 266 nm UVPD using 
one laser pulse at approximately 6 mJ of energy, followed by CID for those peptides which 
exhibited neutral losses characteristic of the SePh tag.  Protein mixtures were prepared and 
analyzed in quadruplicate, and single protein digests were analyzed in triplicate. The overall 
experimental workflow is presented in Scheme 2.2.  In brief, proteins are digested, reduced, 
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derivatized with NPSP, analyzed by LC-MS/MS using the UVPDnLossCID scan mode, 
then subjected to a cysteine-selective database search.   
 
Scheme 2.2. Overall experimental workflow for selective characterization of cysteine-
containing peptides 
Database Searching 
Data files were converted to the mzXML format using the software MM File 
Conversion and submitted to MassMatrix for analysis [80–83].  For UVPDnLossCID 
data, a filtering step was performed in SEQUEST which removed all UVPD scans 
leaving only CID MS/MS events in an exported MGF file which was submitted to 
MassMatrix for analysis. Fragment ion databases were built upon FASTA files obtained 
from Uniprot, and the resulting theoretical fragment ions were compared to the 
experimental results.  A custom version of the algorithm was implemented which allowed 
solely cysteine-containing peptides to be searched.  A maximum of three modifications 
per peptide was searched with variable modifications of oxidation of methionine and 
alkylation of cysteine by NPSP.  Peptides with a statistical p value of < 0.05 (as 
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calculated based on the pptag, pp2, pp scores, all which are scoring parameters used to 
estimate the quality of peptide-spectrum matches) [81] were considered significant.  
Decoy hits were excluded from the reported results.    
Safety Considerations 
 N-(Phenylseleno)phthalimide (NPSP) is a hazardous chemical which is classified as 
a health hazard having the potential to cause acute toxicity and is also dangerous for the 
environment.  Precautions for working with this chemical should be taken by wearing a 
dust mask and using a fume hood.   
RESULTS 2.4 
NPSP Reaction efficiency and MS/MS for Model Peptides 
Since this strategy depends on efficient tagging of cysteines, initial efforts focused 
on optimization of the NPSP derivatization reaction and measurement of reaction efficiency.  
Figure 2.1 shows a comparison of the ESI mass spectra obtained for a model peptide, 
CDPGYIGSR, prior to and after reaction with NPSP.  The addition of the benzeneselenol 
group (ΔM = +155.9 Da) to the free cysteine thiol of CDPGYIGSR is highly efficient with 
little unreacted peptide observed in Figure 2.1b. The relative abundances of the 1+ and 2+ 
charge states for both the unmodified and modified peptides remain similar, thus indicating 
that the benzenselenol tag does not have a significant effect on charging of the peptide.   
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Figure 2.1. ESI mas spectra of (a) unmodified and (b) SePh-modified peptide 
CDPGYIGSR with insets showing characteristic Se isotope pattern of the 2+ 
charge state 
CID was used to characterize the fragmentation patterns of the unmodified and 
modified CDPGYIGSR peptide (2+) as shown in Figure 2.2.  While there are some modest 
differences in the types and relative abundances of the diagnostic b/y sequence ions, the 
overall sequence coverage is comparable for both the unmodified and NPSP-tagged 
peptides.  Owing to the fact that the cysteine is located on the N-terminus, all characteristic 
b-type ions observed in Figure 2.2b retain the benzeneselenol group after CID.  Thus, the 
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benzeneselenol group is not labile, and the peptide can be readily identified based on the 
conventional b/y product ions.   
 
Figure 2.2. CID mass spectra of (a) CDPGYIGSR (2+) and (b) SePh-modified 
CDPGYIGSR (2+). 
Unmodified peptides, as exemplified by CDPGYIGSR (2+) (Figure 2.3a), yielded 
no product ions upon 266 nm UVPD.  The peptide backbone does not efficiently absorb at 
266 nm, and the sole aromatic chromophore of Tyr (Y) does not result in significant 
absorption and dissociation upon exposure to a single laser pulse.  When the 2+ charge state 
of the NPSP-modified CDPGYIGSR peptide was subjected to 266 nm UV photoactivation 
(one laser pulse), the sole prominent product arose from Se-S cleavage corresponding to loss 
of the benzeneselenol group (Figure 2.3b). The loss of the benzeneselenol group results in a 
product that is 1 Da less than the unmodified peptide, suggesting that 266 nm UVPD occurs 
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via homolytic cleavage of the Se-S bond to yield a thiol radical which presumably may 
undergo subsequent electron migration.  CID of the resulting Se-S cleavage product (the 
presumed radical thiol peptide species) was performed, resulting in low abundance ions 
which were difficult to assign as traditional a, b, c, x, y, z ions (spectrum not shown).  
Nonetheless, irradiation of the NPSP-modified peptides by 266 nm photons resulted in 
highly selective preferential cleavage of the Se-S bond and loss of the benzeneselenol group, 
thus affording a highly characteristic neutral loss pathway for NPSP-labelled cysteine-
containing peptides. 
 
Figure 2.3. 266 nm UVPD mass spectra of (a) unmodified and (b) modified 
CDPGYIGSR (2+) as well as (c) unmodified and (d) modified somatostatin 
AGCKNFFWKTFTSC (2+) exhibiting the characteristic neutral loss of the 
SePh group from the modified peptides. 
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As another example, somatostatin (AGCKNFFWKTFTSC) contains a disulfide bond 
between Cys3 and Cys14 and was used to optimize the reaction efficiency for disulfide-
bound cysteine residues. Upon reaction with NPSP, two benzeneselenol (Δm = 311.9 Da) 
groups were appended to somatostatin (Figure 2.4), and the bis-labelled peptide was the 
dominant product. The doubly NPSP-modified AGCKNFFWKTFTSC peptide was 
subjected to 266 nm UVPD, and the resulting mass spectrum is shown in Figure 2.3d (and 
266 nm UVPD of unmodified somatostatin is shown in Figure 2.3c).  The exclusive product 
arose from the loss of both benzeneselenol tags via cleavage of both Se-S bonds. 
Interestingly, a product corresponding to cleavage of a single Se-S bond was not observed.  
The clean loss of both tags from the doubly-modified peptide was an unexpected and 
striking result that attests to the lability of the Se-S bonds upon UVPD.  Comparison of the 
UVPD mass spectra in Figure 2.3d for the doubly-modified peptide 
(AGC*KNFFWKTFTSC*) to that observed for the singly-modified peptide (C*DPGYIGSR) 
in Figure 2.3b demonstrates that the UVPD efficiency was significantly greater for the 
doubly NPSP-modified peptide.  We rationalize this outcome owing to greater molar 
absorptivity of the doubly-modified peptide due to the addition of the second SePh group. 
These proof-of-principle experiments with model peptides demonstrated that 266 nm UVPD 
promoted highly efficient Se-S cleavage and thus proved to be very selective for cysteine-
containing peptides that contained the benzeneselenol tag.   Using UVPD as the first step of 
a data-dependent MS/MS strategy allows ready pinpointing of the cysteine-containing 
peptides based on the characteristic loss of the SePh groups, then CID is subsequently 
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triggered for those peptides to characterize the sequences.  The net method is termed 
UVPDnLossCID. 
 
Figure 2.4. ESI mass spectra of (a) unmodified and (b) SePh-modified peptide 
somatostatin (AGCKNFFWKTFTSC) with insets showing unique Se 
isotope pattern of the 2+ charge state 
Previous reports have indicated that ETD also provides a way to cleave S-Se bonds 
[28], and thus the performance of ETD was compared to UVPD for both singly modified 
CDPGYIGSR (Figure 2.5a) and bis-modified AGCKNFFWKTFTSC (somatostatin) 
(Figure 2.5b). For both singly NPSP-modified CDPGYIGSR and doubly NPSP-modified 
somatostatin, the dominant pathway upon ETD was charge reduction and S-Se cleavage 
resulting in the neutral loss of the benzeneselenol group.   A few sequence-type ions were 
observed, as well as notable ETnoD products. The loss of both tags from the bis-labeled 
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peptide is a minor pathway (less than 1% abundance relative to the precursor.  The 
efficiency of the S-Se cleavage is lower for ETD than for UVPD. UVPD offered a more 
efficient means to cleave all S-Se bonds simultaneously in a faster activation period and 
without any charge-state dependence, so it was used as the activation method of choice for 
the rest of the study.      
 
Figure 2.5. ETD mass spectra of (a) SePh-modified CDPGYIGSR (2+, 100 ms) and (b) 
SePh-modified AGCLNFFWKTFTSC (somatostatin) (2+, 100 ms) showing 
charge reduction and neutral losses of SePh. 
 
Derivatization of Protein Digests 
The NPSP reaction and UVPDnLossCID method was optimized for identification of 
cysteine-containing peptides based on examination of tryptic digests of cytochrome C and 
bovine serum albumin (BSA). Using the new UVPDnLoss CID scan mode, any ion 
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displaying the targeted neutral loss corresponding to the cleavage of one or more SePh tags 
was selected for characterization in a second CID event (NCE 35). Neutral losses for peptide 
ions containing up to two cysteine modifications of NPSP were monitored as follows: -156 
or -312 Da for 1+ peptides, -78 or -156 Da for 2+ peptides, and -52 or -104 for 3+ peptides. 
In brief, typical experiments involved 266 nm UVPD, followed by isolation and CID of any 
ion which exhibited one of the specified neutral losses upon UVPD.  The base peak 
chromatogram of the cyt C digest is shown in Figure 2.6a, and another is shown in Figure 
2.6b for a BSA digest with all cysteine-containing peptides labelled. As a simple example, 
cytochrome c contains two cysteine residues, and tryptic digestion results in a single peptide 
containing both cysteine residues (CAQCHTVEK).  After reduction of the peptide, 
alkylation of CAQCHTVEK with NPSP yielded a mass shift of 311.9 Da.  The bis-labeled 
tryptic peptide (C*AQC*HTVEK) is shown in Figure 2.7a. The UVPD spectrum is shown 
in Figure 2.7b and exhibits a single product due to cleavage of both SePh tags, and the 
subsequent neutral-loss triggered CID spectrum of the original tagged peptide is displayed 
in Figure 2.7c. The protein BSA, containing 35 cysteine residues and 17 disulfide bonds, 
provided a larger number of cysteine-containing peptides (as labeled in Figure 2.6b).  
Fourteen of the cysteine-containing tryptic peptides generated from BSA were successfully 
characterized using the UVPDnLossCID method. The complete lists of all peptides 
identified in the tryptic digests of cyt C and BSA are provided in Tables 2.1 and 2.2.  
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Figure 2.6. LC traces of tryptic digests of (a) cytochrome C (horse) and (b) bovine serum 
albumin.  The cysteine-containing SePh-modified peptides are labelled, and 
the ones for BSA are listed in the table below the LC trace.   
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Figure 2.7. (a) ESI mass spectrum of the tryptic peptide CAQCHTVEK eluting at 61.13 
minutes in the LC trace shown in Figure 2a, and (b) UVPD mass spectrum 
of C*AQC*HTVEK (2+), and (c) UVPDnLossCID spectrum. 
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Table 2.1. All identified peptides for Cytochrome C (Figure 2.6a) from MassMatrix 
Search algorithm and their corresponding charge states and retention times.  
(Note: seph(residuenumber) is representative of an addition of SePh). 
Peptide + Modification 
Retention Time 
(Min) 
Charge 
States 
CAQCHTVEK 41.95 2+  
CAQCHTVEK seph(1) 42.95 2+  
CAQCHTVEK seph(1) seph(4) 70.35 2+ 1+  
CAQCHTVEK seph(4) 47.73 2+  
CAQCHTVEKGGKHK 81.81 3+  
EDLIAYLK 80.46 2+ 1+  
EDLIAYLKK 63.61 1+ 2+  
EETLMEYLENPK 74.34 2+ 3+ 1+  
EETLMEYLENPK OxiM(5) 60.67 2+ 3+  
EETLMEYLENPKK 70.07 3+ 2+ 1+  
EETLMEYLENPKK OxiM(5) 73.4 3+ 2+  
EETLMEYLENPKKYIPGTK OxiM(5) 66.68 3+  
GITWKEETLMEYLENPK 76.59 3+ 2+  
GITWKEETLMEYLENPK OxiM(10) 70.9 3+ 2+  
GITWKEETLMEYLENPKK 73.16 3+ 2+  
GITWKEETLMEYLENPKK OxiM(10) 67.22 3+ 2+  
IFVQKCAQCHTVEK 49.26 3+  
IFVQKCAQCHTVEK seph(6) 59.08 3+  
IFVQKCAQCHTVEK seph(9) 55.3 3+  
KIFVQK 45.04 1+  
KTEREDLIAYLK 61.06 3+ 2+ 1+  
KTGQAPGFTYTDANK 53.84 3+ 2+  
KYIPGTK 41.63 2+ 1+  
MGDVEKGK 46.29 2+  
MGDVEKGKK 81.97 2+  
MIFAGIK 62.92 1+  
MIFAGIKK 55.72 2+  
MIFAGIKK OxiM(1) 49.98 2+  
MIFAGIKKK 47.69 2+  
NKGITWK 65.13 2+  
NKGITWKEETLMEYLENPK OxiM(12) 69.85 3+  
TEREDLIAYLK 65.68 2+ 3+  
TEREDLIAYLKK 60.3 3+ 2+  
TGPNLHGLFGR 67.83 2+ 1+  
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Table 2.1 (continued) 
TGQAPGFTYTDANK 44.87 2+ 1+ 3+  
YIPGTK 43.23 1+  
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Table 2.2. All identified peptides for BSA (Figure 2.6b) from MassMatrix Search 
algorithm and their corresponding charge states and retention times.  (Note: 
seph(residuenumber) is representative of an addition of SePh). 
Peptide + Modification 
Retention Time 
(Min) Charge States 
ADLAKYICDNQDTISSK seph(8) 69.57 3+  
AEFVEVTK 43.61 2+ 1+  
AEFVEVTKLVTDLTK 74.44 2+ 3+  
ALKAWSVAR 45 2+  
ATEEQLK 30.08 2+ 1+  
ATEEQLKTVMENFVAFVDK 82.73 3+ 2+  
ATEEQLKTVMENFVAFVDK OxiM(10) 70.42 3+ 2+  
AWSVAR 40.07 1+  
CASIQK seph(1) 47.06 1+  
CASIQKFGER seph(1) 32.97 3+  
CASIQKFGERALK 57.64 3+  
CCAADDK seph(1) seph(2) 43.42 2+  
CCAADDKEACFAVEGPK seph(1) 62.15 3+  
CCAADDKEACFAVEGPK seph(1) seph(2) seph(10) 82.1 3+  
CCAADDKEACFAVEGPK seph(10) 63.51 3+  
CCAADDKEACFAVEGPK seph(2) 60.14 3+  
CCTESLVNR 42.64 2+  
CCTESLVNR seph(1) seph(2) 77.09 2+  
CCTESLVNRR seph(1) 37.32 3+  
CCTESLVNRR seph(2) 41.28 3+  
CCTKPESER 31.38 2+  
CCTKPESERMPCTEDYLSLILNR 76.65 3+  
DAFLGSFLYEYSR 92.88 1+ 3+ 2+  
DAIPENLPPLTADFAEDK 66.92 3+ 2+  
DAIPENLPPLTADFAEDKDVCK seph(21) 77.2 3+ 2+  
DAIPENLPPLTADFAEDKDVCKNYQEAK seph(21) 73.08 3+  
DDPHACYSTVFDK seph(6) 66.02 3+ 2+  
DDPHACYSTVFDKLK seph(6) 69.66 3+  
DDSPDLPK 37.87 2+ 1+  
DLGEEHFK 42.15 2+ 1+  
EACFAVEGPK seph(3) 66.84 2+  
ECCDKPLLEK 42.64 2+  
ECCHGDLLECADDR 91.62 3+  
ECCHGDLLECADDR seph(10) 67.32 3+  
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Table 2.2 (continued) 
ECCHGDLLECADDR seph(2) 78.86 3+  
ECCHGDLLECADDR seph(3) 80.31 3+  
EKVLASSAR 78.71 2+  
ETYGDMADCCEK OxiM(6) 36.03 2+  
ETYGDMADCCEKQEPER OxiM(6) 37.62 3+  
EYEATLEECCAK 50.4 2+  
EYEATLEECCAK seph(9) seph(10) 42.53 3+  
EYEATLEECCAKDDPHACYSTVFDK seph(18) 65.64 3+  
EYEATLEECCAKDDPHACYSTVFDK seph(9) 65.94 3+  
FGERALK 59.81 2+  
FKDLGEEHFK 45.87 2+ 3+  
FPKAEFVEVTK 51.58 3+ 2+  
GACLLPK seph(3) 29.67 2+  
GACLLPKIETMREK 74.62 3+  
GACLLPKIETMREK OxiM(11) 69.57 3+  
GLVLIAFSQYLQQCPFDEHVK seph(14) 92.37 3+  
HLVDEPQNLIK 50.68 2+ 1+ 3+  
HLVDEPQNLIKQNCDQFEK seph(14) 69.9 3+ 2+  
HPEYAVSVLLR 58.16 2+ 1+ 3+  
HPYFYAPELLYYANK 69.99 3+ 2+  
IETMREK 29.9 2+  
IETMREK OxiM(4) 28.13 2+  
KQTALVELLK 56.62 2+ 1+  
KVPQVSTPTLVEVSR 57.22 3+ 2+  
KVPQVSTPTLVEVSRSLGK 58.74 3+  
LCVLHEK 39.25 2+  
LCVLHEK seph(2) 57.43 2+  
LCVLHEKTPVSEK seph(2) 55.35 3+  
LCVLHEKTPVSEKVTK 39.79 3+  
LCVLHEKTPVSEKVTK seph(2) 53.81 3+  
LFTFHADICTLPDTEK seph(9) 80.13 2+ 3+  
LGEYGFQNALIVR 63.94 2+ 1+ 3+  
LKECCDK seph(5) 53.77 2+  
LKECCDKPLLEK 43.98 3+ 2+  
LKECCDKPLLEK seph(4) seph(5) 70.61 3+  
LKHLVDEPQNLIK 49.38 2+ 3+  
LKPDPNTLCDEFK seph(9) 74.05 2+ 3+  
LKPDPNTLCDEFKADEK 49.64 2+  
LKPDPNTLCDEFKADEK seph(9) 70.29 3+ 2+  
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Table 2.2 (continued) 
LSQKFPK 35.87 2+  
LSQKFPKAEFVEVTK 50.6 2+ 3+  
LVNELTEFAK 57.53 2+ 1+  
LVTDLTK 41.82 1+  
LVVSTQTALA 53.01 1+ 2+  
MPCTEDYLSLILNR 81 2+ 3+  
MPCTEDYLSLILNR OxiM(1) 78.57 3+ 2+  
MPCTEDYLSLILNR OxiM(1) seph(3) 82.29 2+ 3+  
MPCTEDYLSLILNR seph(3) 77.55 2+  
NECFLSHKDDSPDLPK seph(3) 60.61 3+ 2+  
NYQEAKDAFLGSFLYEYSR 71.96 3+ 2+  
PCFSALTPDETYVPK 87.73 2+  
PCFSALTPDETYVPK seph(2) 74.14 3+ 2+  
PDPNTLCDEFK 50.45 2+  
PDPNTLCDEFK seph(7) 72.99 3+ 2+  
PDPNTLCDEFKADEK seph(7) 70.46 2+ 3+  
PLLEKSHCIAEVEK 35.55 3+  
QEPERNECFLSHKDDSPDLPK seph(8) 58.25 3+  
QIKKQTALVELLK 54.6 3+  
QNCDQFEK 40.02 2+  
QNCDQFEK seph(3) 55.18 2+  
QNCDQFEKLGEYGFQNALIVR seph(3) 77.64 3+  
QRLRCASIQK 47.15 3+  
QTALVELLK 62.8 2+ 1+  
QTALVELLKHKPK 51.46 3+  
RHPEYAVSVLLR 78.92 3+ 2+  
RHPEYAVSVLLRLAK 52.67 3+  
RHPYFYAPELLYYANK 64.89 3+ 2+  
RPCFSALTPDETYVPK 74.69 3+ 2+  
RPCFSALTPDETYVPK seph(3) 78.74 3+ 2+  
SHCIAEVEK seph(3) 52.43 2+  
SLGKVGTRCCTK 44.13 3+  
SLGKVGTRCCTK seph(10) 40.53 3+  
SLHTLFGDELCK 91.84 3+ 2+  
SLHTLFGDELCK seph(11) 75.76 3+ 2+ 1+  
TCVADESHAGCEK 31.69 3+  
TCVADESHAGCEK seph(11) 35.88 3+  
TCVADESHAGCEK seph(2) seph(11) 60.61 3+ 2+  
TPVSEK 28.15 1+  
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Table 2.2 (continued) 
TPVSEKVTK 30.78 2+  
TPVSEKVTKCCTESLVNR 76.67 3+  
TVMENFVAFVDK 71.65 2+ 1+ 3+  
TVMENFVAFVDK OxiM(3) 61.97 2+ 3+  
TVMENFVAFVDKCCAADDK OxiM(3) 64.02 3+  
TVMENFVAFVDKCCAADDKEACFAVEGPK + 
seph(13, 14, 22) 92.55 3+  
VPQVSTPTLVEVSR 55.26 2+ 3+  
VTKCCTESLVNR seph(4) 54.83 3+  
VTKCCTESLVNR seph(4) seph(5) 40.67 3+  
YICDNQDTISSK 38.26 2+  
YICDNQDTISSK seph(3) 61.9 2+  
YLYEIAR 49.79 2+ 1+  
YLYEIARR 45.55 2+  
YNGVFQECCQAEDK 51.27 2+  
YNGVFQECCQAEDKGACLLPK seph(17) 72.4 3+  
YNGVFQECCQAEDKGACLLPK seph(8) 72.76 3+  
  
A more complex mixture comprised of eight protein inclusing cytochrome C, 
myoglobin, α-lactalbumin, β-lactoglobulin A/B, carbonic anhydrase II, fetuin B, and 
bovine serum albumin (BSA) was digested, derivatized, and analyzed.  The resulting 
analysis of the number of unique cysteine-containing PSMs and the total number of 
unique PSMs (i.e. both cysteine-containing and non-cysteine-containing peptides) for this 
mixture is shown in Figure 2.8.  As illustrated, conventional CID and HCD returned 
large numbers of total PSMs (Figure 2.8a) and unique PSMs (Figure 2.8b), and there is 
no selectivity for cysteine-containing peptides (as expected for any type of non-targeted 
search).  UVPDnLossCID yielded a much smaller number of total PSMs and unique 
PSMs, an outcome arising from the significant selectivity of the UVPDnLossCID method 
for targeting cysteine-containing peptides.  Additionally, all seven of the cysteine-
containing proteins were identified from a unique peptide surrogate in at least three out of 
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four of the experimental replicates using the UVPDnLossCID method (the replicate LC 
traces are depicted in Figure 2.9). A filtered database search in a regular proteomics 
experiment can be thought of as an “incomplete database” when used to search a tryptic 
digest, a factor known to inhibit peptide identification by causing a higher false discovery 
rate [84].  When the filtered database search is restricted to only MS/MS events that 
exclusively sequence peptides contained in a database, then this problem is resolved and 
the chance of a false positive is decreased.   
 
Figure 2.8. Bar charts depicting the (a) total PSMs and (b) unique PSMs from a full 
database search versus a cysteine-only database search based on spectra 
obtained from the different activation methods.   
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Figure 2.9. Base peak chromatograms of four NPSP-derivatized tryptic digests of protein 
mixtures on a C18 column. 
Some cysteine-containing peptides were not identified by the UVPDnLossCID 
method, and this is attributed to a threshold parameter included in the triggering of the CID 
step for those peptides identified by UVPD to contain cysteine based on the neutral loss of 
the SePh tag.  This threshold was set so that the neutral loss product must be at least 10% 
of the precursor ion abundance, thus preventing excessive false triggering of the subsequent 
CID scan. The UVPDnLossCID method also resulted in a few false positives, an outcome 
related to the rather broad and complex isotope pattern associated with selenium-containing 
peptide precursors compared to the more narrow isotope pattern after loss of the SePh tag.  
This change in isotope pattern, although an interesting signature, requires use of a larger 
than normal mass tolerance for the neutral loss transition to compensate for potential 
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activation of the non-SePh-tagged peptide precursor monoisotopic (where monoisotopic 
signifies the species composed of the most abundant isotopes of each constituent element). 
By using a custom version of the MassMatrix database search algorithm which 
allowed searching only cysteine-containing peptides, two significant improvements are 
gained due to a reduced search space.  First, the confidence level of PSMs is increased 
when a smaller, targeted database is employed to search data.  For example, when 
searching the E. coli proteome without any database filtering, approximately 885,190 
peptide sequences (counting variable modifications) were included in the search.  After 
cysteine-selective peptide filtering, this number was reduced to 160,273 (82% reduction).  
The MassMatrix scoring algorithm evaluates peptides on the basis of a pp score which is 
equivalent to −log⁡(p⁡value).  The p-value is a measurement of the probability that a 
peptide match is random.  With a significant search space reduction, the p-value and pp 
scores do not change.  The confidence value of a match is defined as: −log⁡(q⁡value), for 
which the q-value is defined as the product of the search space and the p-value.  In essence, 
the q-value represents the number of random matches that are expected in a given search 
space.  Thus, while p-score metrics remain constant, the confidence scores increase due to 
database filtering and yield smaller (better) q values.  To illustrate this point, the relative 
frequencies of each of the 20 amino acids found in all known proteins in the E. coli 
proteome are depicted in Figure 2.10a.  As expected, cysteine was found to be the least 
abundant (least frequent) amino acid, meaning that it offers the potential for the greatest 
gain in PSM confidence in restricted database searches for bottom-up proteomics 
applications. Figure 2.10b graphically depicts an example of the logarithmic gains in 
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confidence achieved relative to the reduction in the size of the search space.  Peptide 
matches are considered significant if a peptide has a p-value of < 0.05. Because q-value is 
the product of the p-value and the size of the search space, Figure 2.10b shows the 
minimum expected gains in confidence. As p-value decreases, confidence increases, 
yielding a minimum expected gain in confidence of 15% for the E. coli analysis utilizing a 
cysteine-restricted database. 
 
Figure 2.10. Statistics representing (a) the percent of tryptic peptides from the E. coli 
proteome containing each amino acid.  Graphical depictions of the effects of 
search space reduction on (b) PSM confidence and (C) computational time.  
In addition to increasing confidence levels, database filtering also expedites 
searches because there are fewer computations to complete the database search.  Big 
Omnicron (“Big-O”) notation is a theoretical metric of an algorithm that measures 
resources used (time, memory, etc.) for a given problem size [85].  For the MassMatrix 
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algorithm used in the present study, the time dependence of the search algorithm is 
related to both: (i) the number of theoretical peptides, and (ii) the number of MS/MS 
spectra in a particular search.  For (i), the number of theoretical peptides is calculated 
with consideration of peptide modifications.  If a peptide sequence has potential 
modifications (such as the SePh tag in this study), it will generate many peptides with the 
same sequence but with different modifications.  The overall time relationship is defined 
as: where M is the number of theoretical peptides and N is the number of 
MS/MS spectra.  The linear decrease in search time for LC-MS/MS experiments for a 
given number of MS/MS spectra is depicted in Figure 2.10c. For UVPDnLossCID, there 
are significantly fewer MS/MS scans accumulated in the search file compared to standard 
top N HCD or CID runs.  The decrease in both the number of MS/MS scans and also the 
number of theoretical peptides results in over an order of magnitude decrease in search 
time. In addition, the number of SePh neutral losses observed upon UVPD could 
conceivably be incorporated into an even more refined search method.  This additional 
metric would count the number of cysteine residues per peptide, offering another means 
to constrain database searches or build more selectivity into a targeted strategy. 
 
A few remarks about the duty cycle of the UVPDnLossCID method relative to other 
MS/MS methods are warranted.  CID, HCD, and 266 nm UVPD have activation periods of 
10, 1, and 2 ms, respectively.  CID and HCD have no intrinsic peptide selectivity, and thus 
a data-dependent acquisition mode that activates the most abundant precursors in a 
spectrum (top N) is typically used. In contrast, UVPDnLossCID is a two-step method with 
UVPD used as the prescreening step followed by CID for sequencing the cysteine-
containing peptides. Combining two sequential steps significantly increases selectivity at 
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the expense of the duty cycle of the method.  It is this loss of duty cycle which presumably 
accounts for why some cysteine peptides were not found using the UVPDnLossCID 
method.  
CONCLUSIONS 2.5 
We have showcased the ability to implement cysteine-based selectivity using 266 
nm UVPD in bottom-up proteomics experiments.  NPSP was used to install a 
photocleavable tag on cysteine residues, resulting in the loss of SePh upon 266 nm 
UVPD.  Development of a customized data-dependent acquisition afforded selective 
sequencing of cysteine peptides to complement the database search.   In essence, 
cysteine-containing peptides are selectively identified based on a UVPDnLossCID mode 
in which the loss of SePh upon 266 nm UVPD is used to trigger CID for characterization 
of those cysteine-containing peptides. Implementation of a filtered cysteine database into 
a database search program allows the highest gains in speed and PSM confidence for 
analysis of a proteomic data-set.   
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Table 2.3.  All identified peptides for the protein mixture (Figure 2.8b) from cysteine 
filtered CID MassMatrix Search algorithm and their corresponding charge 
states and retention times.  (Note: seph(residuenumber) is representative of 
an addition of SePh). 
Peptide + Modification 
Retention Time 
(Min) 
Charge 
States 
AACVWNGLSYGRYNDLGHRK seph(3) 17.82 3+  
ALATQTSVVLKPGEVAFCAEK seph(18) 21.91 3+  
ALATQTSVVLKPGEVAFCAEKDDAACCK seph(26) 7.68 3+  
ALATQTSVVLKPGEVAFCAEKDDAACCK seph(27) 7.68 3+  
CAQCHTVEK seph(1) seph(4) 51.71 1+ 2+  
CAQCHTVEK seph(4) 37.53 2+  
CAQCHTVEKGGK seph(1) 32.82 3+  
CASIQKFGER seph(1) 44.75 2+  
CCAADDKEACFAVEGPK seph(1) 54.31 3+  
CCAADDKEACFAVEGPK seph(10) 54.31 2+ 3+  
CCAADDKEACFAVEGPK seph(2) 54.31 2+ 3+  
CCTESLVNR seph(1) seph(2) 66.35 2+  
CELAAAMK seph(1) 53.99 1+ 2+  
CELAAAMK seph(1) OxiM(7) 45.88 2+  
CELAAAMKR seph(1) 49.61 2+  
CELAAAMKR seph(1) OxiM(7) 41.9 2+  
CEVFR seph(1) 52.5 1+  
CEVFRELKDLK seph(1) 58.33 3+  
CGRIWAQVDTGKCR seph(1) 26.12 3+  
CKGTDVQAWIR seph(1) 54.73 2+ 3+  
CKGTDVQAWIRGCRL seph(1) seph(13) 73.55 3+  
CKPVNTFVHESLADVQAVCSQK seph(1) seph(19) 80.16 3+  
CKPVNTFVHESLADVQAVCSQK seph(19) 91.05 3+  
CLEDGFLTHLSKECGAHSEDAVCTK seph(1) 78.46 3+  
CRDKTLNRSK seph(1) 58.22 3+  
CRNRWAVWANMGNGDSVIK seph(1) 75.42 3+  
DAIPENLPPLTADFAEDKDVCK seph(21) 67.23 2+ 3+  
DAIPENLPPLTADFAEDKDVCKNYQEAK seph(21) 62.94 3+  
DCCEKLKSSITDQNDCIYK seph(2) seph(3) seph(16) 79.08 3+  
DDPHACYSTVFDK seph(6) 56.56 2+ 3+  
DDPHACYSTVFDKLK seph(6) 15.95 3+  
DDQNPHSSNICNISCDK seph(11) seph(15) 69.75 2+ 3+  
EACFAVEGPK seph(3) 57.47 2+  
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Table 2.3 (continued) 
ECCHGDLLECADDR seph(10) 53.12 3+  
ECCHGDLLECADDR seph(2) 54.57 3+  
ECCHGDLLECADDR seph(2) seph(3) seph(10) 76.06 3+  
ECCHGDLLECADDR seph(3) 54.57 3+  
ESPCVK seph(4) 48.42 2+  
EYEATLEECCAK seph(9) seph(10) 54.45 2+ 3+  
EYEATLEECCAKDDPHACYSTVFDK seph(10) 55.29 3+  
EYEATLEECCAKDDPHACYSTVFDK seph(18) 66.42 3+  
EYEATLEECCAKDDPHACYSTVFDK seph(9) 55.29 3+  
FLDDDLTDDIMCVK OxiM(11) seph(12) 67.09 2+  
FLDDDLTDDIMCVK seph(12) 70.41 2+  
GACLLPK seph(3) 56.98 2+  
GTDVQAWIRGCRL seph(11) 71.62 3+  
GYSLGNWVCAAK seph(9) 70.07 1+ 2+  
GYSLGNWVCAAKFESNFNTQATNR seph(9) 90.76 3+  
HGLDNYRGYSLGNWVCAAK seph(16) 59.36 3+  
HIIVACEGNPYVPVHFDASV seph(6) 9.04 2+ 3+  
HLVDEPQNLIKQNCDQFEK seph(14) 58.63 3+  
IFHESVYGQCK seph(10) 48.71 3+  
IFVQKCAQCHTVEK seph(6) 18.18 3+  
IQKETDPLTCIDAHFTFLK seph(10) 88.81 3+  
IWCKDDQNPHSSNICNISCDK seph(3) 46.99 3+  
KACNVSATIDSSLLASCPINCLNR seph(3) seph(17) 
seph(21) 80.45 3+  
KVFGRCELAAAMKR seph(6) 50.61 3+  
KVFGRCELAAAMKR seph(6) OxiM(12) 45 3+  
LCVLHEK seph(2) 78.57 2+  
LCVLHEKTPVSEKVTK seph(2) 43.42 3+  
LDQWLCEK seph(6) 67.02 1+ 2+  
LFTFHADICTLPDTEK seph(9) 71.27 2+ 3+  
LKECCDKPLLEK seph(4) seph(5) 60.92 2+ 3+  
LKPDPNTLCDEFK seph(9) 64.54 2+ 3+  
LKPDPNTLCDEFKADEK seph(9) 59.82 2+ 3+  
LRCASIQKFGER seph(3) 50.1 3+  
LRCASIQKFGERALK seph(3) 48.38 3+  
LSFNPTQLEEQCHI seph(12) 76.26 1+ 2+  
MMQNCYNSSSAASTSSDMHQREFK OxiM(1) OxiM(2) 
seph(5) 7.94 3+  
MPCTEDYLSLILNR OxiM(1) seph(3) 72.5 2+ 3+  
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Table 2.3 (continued) 
MPCTEDYLSLILNR seph(3) 77.68 2+ 3+  
MPCTEDYLSLILNRLCVLHEK seph(16) 88.43 3+  
NECFLSHK seph(3) 48.97 2+  
NECFLSHKDDSPDLPK seph(3) 50.77 2+ 3+  
NGQTNCYQSYSTMSITDCR OxiM(13) seph(18) 88.81 3+  
NLCNIPCSALLSSDITASVNCAK seph(21) 72.69 2+ 3+  
NLCNIPCSALLSSDITASVNCAK seph(3) seph(7) seph(21) 91.49 2+  
NRCKGTDVQAWIR seph(3) 49.91 3+  
QEPERNECFLSHK seph(8) 46.13 3+  
QEPERNECFLSHKDDSPDLPK seph(8) 46.27 3+  
QHMDSSTSAASSSNYCNQMMKSR seph(16) OxiM(19) 36.1 3+  
QHMDSSTSAASSSNYCNQMMKSR seph(16) OxiM(20) 36.1 3+  
QNCDQFEK seph(3) 45.38 2+  
QNCDQFEKLGEYGFQNALIVR seph(3) 67.68 3+  
RHGLDNYRGYSLGNWVCAAK seph(17) 56.69 3+  
RPCFSALTPDETYVPK seph(3) 38.49 2+ 3+  
SAECPGPAQK seph(4) 27.18 2+  
SAECPGPAQKGYPFILPS seph(4) 16.58 3+  
SHCIAEVEK seph(3) 42.33 2+  
SLHTLFGDELCK seph(11) 67.23 1+ 2+ 3+  
SLHTLFGDELCKVASLR seph(11) 71.51 3+  
TCVADESHAGCEK seph(2) seph(11) 49.13 2+  
TCVADESHAGCEKSLHTLFGDELCK seph(24) 87.71 3+  
TPVSEKVTKCCTESLVNR seph(10) 21.02 3+  
TTQANKHIIVACEGNPYVPVHFDASV seph(12) 63.04 2+ 3+  
VASLRETYGDMADCCEKQEPER OxiM(11) seph(15) 91.97 3+  
VFGRCELAAAMKR seph(5) 40.87 3+  
VFGRCELAAAMKR seph(5) OxiM(11) 31.62 3+  
VHKECCHGDLLECADDR seph(13) 50.74 3+  
VHKECCHGDLLECADDR seph(5) 46.23 3+  
VHKECCHGDLLECADDR seph(5) seph(6) seph(13) 65.3 3+  
VHKECCHGDLLECADDR seph(6) 46.23 3+  
VLCQCVLSQEPEASNEMCFLLYK seph(3) 7.42 3+  
VLCQCVLSQEPEASNEMCFLLYK seph(5) 7.42 3+  
VTKCCTESLVNR seph(4) 38.63 3+  
VYVEELKPTPEGDLEILLQKWENGECAQK seph(26) 65.45 3+  
WENDECAQK seph(6) 50.17 2+ 3+  
WENGECAQKK seph(6) 19.92 3+  
WWCNDGR seph(3) 61.81 2+  
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WWCNDGRTPGSR seph(3) 56.15 3+  
YICDNQDTISSK seph(3) 52.48 1+ 2+  
YICDNQDTISSKLK seph(3) 92.47 2+  
YNGVFQECCQAEDK seph(8) seph(9) 75.38 2+  
YPNCAYK seph(4) 48.84 2+  
 
  
 63 
Table 2.4. All identified peptides for the protein mixture (Figure 2.8b) from full CID 
MassMatrix Search algorithm and their corresponding charge states and 
retention times.  (Note: seph(residuenumber) is representative of an addition 
of SePh). 
Peptide + Modification 
Retention Time 
(Min) 
Charge 
States 
ADEKKFWGK 21.34 2+  
AEFVEVTK 31.87 1+ 2+  
AEFVEVTKLVTDLTK 63.79 3+ 2+  
AIFYINK 41.06 1+ 2+  
ALELFR 45.17 1+  
ALELFRNDIAAK 47.1 3+ 2+  
ALELFRNDIAAKYK 49.65 3+  
ALKALPMHIR 99.35 2+  
ALKAWSVAR 33.24 2+  
ALPMHIR 49.84 2+  
ALPMHIR OxiM(4) 89.73 2+  
ASEDLKKHGTVVLTALGGILK 54.18 3+  
ATEEQLK 15.83 2+ 1+  
ATEEQLKTVMENFVAFVDK 72.97 3+  
AVLKDGPLTGTYR 36.13 3+  
AVVQDPALK 29.5 2+  
AVVQDPALKPLALVYGEATSR 59.02 3+ 2+  
AVVQDPALKPLALVYGEATSRR 71.95 3+  
AWSVARLSQKFPK 48.54 3+  
CAQCHTVEK 15.86 2+  
CAQCHTVEK seph(1) 51.05 2+  
CAQCHTVEK seph(1) seph(4) 49.78 2+ 1+  
CAQCHTVEK seph(4) 37.53 2+  
CAQCHTVEKGGK 45.12 3+  
CAQCHTVEKGGKHK 9.44 3+  
CASIQK 85.04 1+  
CASIQKFGER seph(1) 44.75 3+ 2+  
CASIQKFGERALK 39.16 3+  
CCAADDKEACFAVEGPK seph(1) 86.16 3+  
CCAADDKEACFAVEGPK seph(10) 49.41 3+  
CCAADDKEACFAVEGPK seph(2) 49.97 3+  
CCTESLVNR 29.66 2+  
CCTESLVNR seph(1) seph(2) 64.84 2+  
 64 
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CCTESLVNRR seph(1) 29.18 3+  
CCTESLVNRR seph(1) seph(2) 45.8 3+  
CCTESLVNRR seph(2) 21.67 3+  
CCTKPESER 13.81 2+  
CCTKPESER seph(1) 41.02 3+  
CCTKPESER seph(1) seph(2) 51.33 2+  
CCTKPESER seph(2) 41.02 3+  
CELAAAMK 36.77 2+  
CELAAAMK OxiM(7) 36.9 2+  
CELAAAMK seph(1) 54.62 2+ 1+  
CELAAAMK seph(1) OxiM(7) 24.86 2+  
CELAAAMKR OxiM(7) 2.59 2+  
CELAAAMKR seph(1) 48.32 2+  
CELAAAMKR seph(1) OxiM(7) 40.32 2+  
CEVFRELKDLK seph(1) 54.25 3+  
CKGTDVQAWIR 31.71 3+  
CKGTDVQAWIR seph(1) 52.8 3+ 2+  
CKPVNTFVHESLADVQAVCSQK seph(1) seph(19) 78.23 3+  
CRDKTLNR 94.43 2+  
DAFLGSFLYEYSR 64.81 2+ 1+  
DAFLGSFLYEYSRR 78.23 2+  
DAIPENLPPLTADFAEDK 56.94 3+ 2+  
DAIPENLPPLTADFAEDKDVCK seph(21) 68.15 3+ 2+  
DAIPENLPPLTADFAEDKDVCKNYQEAK seph(21) 62.94 3+  
DDPHACYSTVFDK 36.67 3+  
DDPHACYSTVFDK seph(6) 56.46 3+ 2+  
DDPHACYSTVFDKLK seph(6) 11.89 3+  
DDQNPHSSNICNISCDK 24.52 3+ 2+  
DDQNPHSSNICNISCDK seph(11) seph(15) 68.11 2+ 3+  
DDSPDLPK 26.17 2+  
DFPIANGER 34.21 2+ 1+  
DFPIANGERQSPVDIDTK 41.84 3+  
DGPLTGTYR 31.4 2+ 1+  
DGYVLSLNR 41.81 2+  
DGYVLSLNRVSDAR 53.8 3+  
DLGEEHFK 26.63 2+  
DRKDGYVLSLNR 9.28 3+ 2+  
DVCKNYQEAK 37.62 3+  
DVCKNYQEAK seph(3) 49.32 3+  
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EACFAVEGPK seph(3) 56.21 2+  
ECCDKPLLEK 32.05 2+  
ECCDKPLLEK seph(2) seph(3) 62.82 3+  
ECCHGDLLECADDR 38.8 3+  
ECCHGDLLECADDR seph(10) 57.87 3+  
ECCHGDLLECADDR seph(2) 26.37 3+  
ECCHGDLLECADDR seph(2) seph(3) seph(10) 76.06 3+  
ECCHGDLLECADDR seph(3) 53.23 3+  
ECCHGDLLECADDR seph(3) seph(10) 2.32 3+  
EDLIAYLK 50.87 2+ 1+  
EDLIAYLKK 45.14 2+  
EETLMEYLENPK 57.51 2+ 3+ 1+  
EETLMEYLENPK OxiM(5) 54.83 2+  
EETLMEYLENPKK 53.76 2+ 3+  
EETLMEYLENPKK OxiM(5) 43.31 3+ 2+  
EETLMEYLENPKKYIPGTK OxiM(5) 15.46 3+  
EKVLASSARQR 60.47 3+  
ELGFQG 36.42 1+  
EPISVSSQQMLK 38.64 2+ 1+  
EPISVSSQQMLK OxiM(10) 15.11 3+ 2+  
EPISVSSQQMLKFR OxiM(10) 35.78 3+  
EQLTKCEVFR 33.4 3+  
EQLTKCEVFRELK 30.43 3+  
EQRSAECPGPAQK 93.03 2+  
ESPCVK seph(4) 45.58 2+  
ETGSSKYPNCAYK 32.84 3+  
ETYGDMADCCEK seph(9) 43.72 3+  
ETYGDMADCCEKQEPER 34.55 3+  
ETYGDMADCCEKQEPER OxiM(6) 25.79 3+  
EYEATLEECCAK 37.89 2+  
EYEATLEECCAK seph(9) seph(10) 54.79 3+  
EYEATLEECCAKDDPHACYSTVFDK seph(10) 55.08 3+  
EYEATLEECCAKDDPHACYSTVFDK seph(18) 56.69 3+  
EYEATLEECCAKDDPHACYSTVFDK seph(9) 55.29 3+  
FDKFKHLK 65.44 2+  
FERQHMDSSTSAASSSNYCNQMMK OxiM(22) OxiM(23) 30.52 3+  
FESNFNTQATNR 30.42 2+ 1+ 3+  
FESNFNTQATNRNTDGSTDYGILQINSR 90.34 3+  
FGERALK 48.38 2+  
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FGERALKAWSVAR 42.29 3+  
FKDLGEEHFK 30.68 3+  
FKHLKTEAEMK OxiM(10) 14.64 3+  
FLDDDLTDDIMCVK 47.15 2+ 3+  
FLDDDLTDDIMCVK OxiM(11) 61.76 2+  
FLDDDLTDDIMCVK OxiM(11) seph(12) 11.29 2+ 3+  
FLDDDLTDDIMCVK seph(12) 70.41 2+  
FLDDDLTDDIMCVKK 89.15 3+  
FMETATESLAK 28.1 2+ 3+  
FMETATESLAK OxiM(2) 32.97 2+  
GACLLPK seph(3) 43 2+  
GACLLPKIETMR 11.2 2+  
GACLLPKIETMR OxiM(11) 44.29 3+  
GACLLPKIETMREK 19.83 2+  
GACLLPKIETMREK OxiM(11) 15.23 3+  
GACLLPKIETMREK seph(3) 84.83 3+  
GDVEKGKK 26.67 2+  
GENATVNQRPANPSK 44.64 3+  
GHHEAELK 20.6 2+  
GHHEAELKPLAQSHATK 20.53 3+  
GITWKEETLMEYLENPK 7.54 3+ 2+  
GITWKEETLMEYLENPKK 55.78 3+  
GLDIQK 24.73 1+  
GLSDGEWQQVLNVWGK 65.27 2+ 3+  
GLSDGEWQQVLNVWGKVEADIAGHGQEVLIR 78.79 3+  
GLVLIAFSQYLQQCPFDEHVK 70.03 3+  
GSVQYLPDWDK 47.6 2+  
GSVQYLPDWDKKR 46.21 3+  
GTDVQAWIR 42.46 2+ 1+  
GTDVQAWIRGCR seph(11) 13.32 2+  
GTDVQAWIRGCRL 47.14 3+  
GTDVQAWIRGCRL seph(11) 70.23 2+ 3+  
GYSLGNWVCAAK 28.01 2+ 3+  
GYSLGNWVCAAK seph(9) 66.44 2+ 1+  
GYSLGNWVCAAKFESNFNTQATNR 90.52 3+  
GYSLGNWVCAAKFESNFNTQATNR seph(9) 90.71 3+  
HALWYNIGVKDLIKK 87.55 2+  
HGLDNYR 19.38 2+  
HGLDNYRGYSLGNWVCAAK 48.35 3+  
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HGLDNYRGYSLGNWVCAAK seph(16) 59.36 3+  
HGTVVLTALGGILK 57.16 2+ 3+  
HGTVVLTALGGILKK 89.95 3+  
HGTVVLTALGGILKKK 68.36 3+  
HIIVACEGNPYVPVHFDASV 35.14 3+  
HIIVACEGNPYVPVHFDASV seph(6) 67.15 3+ 2+  
HKTGPNLHGLFGR 36.19 3+  
HKTGPNLHGLFGRK 20.74 2+ 3+  
HLVDEPQNLIK 38.74 3+ 1+ 2+  
HLVDEPQNLIKQNCDQFEK seph(14) 58.63 3+  
HPEYAVSVLLR 46.86 1+ 3+ 2+  
HPGDFGADAQGAMTK 30.14 3+ 2+  
HPGDFGADAQGAMTK OxiM(13) 24.75 3+ 2+  
HPYFYAPELLYYANK 57.5 3+ 2+  
IDALNENK 23 2+ 1+  
IDALNENKVLVLDTDYK 48.48 3+  
IDALNENKVLVLDTDYKK 44.77 3+  
IETMREKVLASSAR 64.89 3+  
IFHESVYGQCK 95.21 3+  
IFHESVYGQCK seph(10) 47.51 3+  
IFVQKCAQCHTVEK 29.52 3+  
IFVQKCAQCHTVEK seph(6) 11.76 3+  
IFVQKCAQCHTVEK seph(9) 77.88 3+  
IFYLPAYNCTLR 13.88 3+  
ILDKVGINYWLAHK 88.35 3+ 2+  
IPAVFK 37.35 1+  
IPAVFKIDALNENK 47.61 3+  
IVSDGNGMNAWVAWR 55.54 2+  
IVSDGNGMNAWVAWR OxiM(8) 45.86 2+  
IWCKDDQNPHSSNICNISCDK seph(3) 46.99 3+  
KDGYVLSLNR 95.62 2+  
KDGYVLSLNRVSDAR 10.82 3+  
KFWGKYLYEIAR 49.06 3+  
KGHHEAELKPLAQSHATK 11.6 3+  
KHGTVVLTALGGILK 92.81 3+  
KILDKVGINYWLAHK 5.21 3+  
KIVSDGNGMNAWVAWR 51.05 3+ 2+  
KIVSDGNGMNAWVAWR OxiM(9) 41.4 3+  
KIVSDGNGMNAWVAWRNR 45.86 3+  
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KKGHHEAELK 0.16 2+  
KQTALVELLK 45.27 2+ 1+  
KTEREDLIAYLK 12.98 3+  
KTGQAPGFTYTDANK 28.99 3+ 2+  
KTGQAPGFTYTDANKNK 25.72 3+  
KVFGRCELAAAMK 38.83 3+  
KVFGRCELAAAMK seph(6) 54.67 3+  
KVFGRCELAAAMK seph(6) OxiM(12) 48.47 3+  
KVPQVSTPTLVEVSR 43.73 3+ 2+  
KYAAELHLVHWNTK 39.22 3+  
KYIPGTK 19.75 2+  
KYLLFCMENSAEPEQSLACQCLVR seph(19) seph(21) 7.88 3+  
LCVLHEK 47.68 2+  
LCVLHEK seph(2) 77.12 2+  
LCVLHEKTPVSEK seph(2) 48.7 3+  
LCVLHEKTPVSEKVTK 5.38 3+  
LCVLHEKTPVSEKVTK seph(2) 41.28 3+  
LDQWLCEK 22.7 2+  
LDQWLCEK seph(6) 59.96 2+ 1+  
LFTFHADICTLPDTEK seph(9) 68.75 2+ 3+  
LFTGHPETLEK 33.13 2+ 3+  
LFTGHPETLEKFDK 10.27 3+  
LFTGHPETLEKFDKFK 44.24 3+  
LGEYGFQNALIVR 53.54 2+ 1+  
LIVTQTMK 32.4 2+ 1+  
LIVTQTMK OxiM(7) 25.72 2+  
LIVTQTMKGLDIQK OxiM(7) 14.26 2+  
LKECCDK 36.8 2+  
LKECCDK seph(5) 26.65 2+  
LKECCDKPLLEK 31.8 3+ 2+  
LKECCDKPLLEK seph(4) seph(5) 58.78 3+ 2+  
LKHLVDEPQNLIK 39.3 3+  
LKPDPNTLCDEFK 63.92 3+  
LKPDPNTLCDEFK seph(9) 62.11 3+ 2+  
LKPDPNTLCDEFKADEK 51.17 3+  
LKPDPNTLCDEFKADEK seph(9) 58.29 3+ 2+  
LRCASIQKFGER seph(3) 92.91 3+ 2+  
LSFNPTQLEEQCHI seph(12) 73.99 2+ 1+  
LSQKFPK 51.54 2+  
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LSQKFPKAEFVEVTK 41.33 3+ 2+  
LVNELTEFAK 46.64 2+ 1+  
LVQFHFHWGSSDDQGSEHTVDR 44.07 3+  
LVTDLTK 30.86 1+  
LVVSTQTALA 41.16 2+ 1+  
MIFAGIK 43.25 1+  
MIFAGIKK OxiM(1) 14 2+  
MMQNCYNSSSAASTSSDMHQR OxiM(2) OxiM(18) 9.32 3+  
MPCTEDYLSLILNR 68.67 3+ 2+  
MPCTEDYLSLILNR OxiM(1) 66.68 3+ 2+  
MPCTEDYLSLILNR OxiM(1) seph(3) 72.5 2+ 3+  
MPCTEDYLSLILNR seph(3) 76.44 2+ 3+  
MVNNGHSFNVEYDDSQDK 33.68 3+ 2+  
MVNNGHSFNVEYDDSQDK OxiM(1) 31.52 3+ 2+  
MVNNGHSFNVEYDDSQDKAVLK 38.27 3+  
MVNNGHSFNVEYDDSQDKAVLK OxiM(1) 38.39 3+  
MVNNGHSFNVEYDDSQDKAVLKDGPLTGTYR 45.08 3+  
NAQTTKYACNPYK 14.19 3+  
NDIAAKYKELGFQG 15.66 2+  
NECFLSHK seph(3) 48.97 2+  
NECFLSHKDDSPDLPK seph(3) 49 2+ 3+  
NECFLSHKDDSPDLPKLK 93.25 3+  
NGQTNCYQSYSTMSITDCR OxiM(13) seph(18) 10.65 3+  
NKGITWK 51.88 2+  
NLCNIPCSALLSSDITASVNCAK seph(21) 90.87 3+  
NRCKGTDVQAWIR 34.62 2+ 3+  
NRCKGTDVQAWIR seph(3) 49.91 3+  
NTDGSTDYGILQINSR 46.84 3+ 2+ 1+  
NYQEAKDAFLGSFLYEYSR 63.17 3+  
PAQPLKNRQVR 36.56 2+ 3+  
PCFSALTPDETYVPK 9.06 2+  
PCFSALTPDETYVPK seph(2) 65.51 3+ 2+  
PDPNTLCDEFK 42.98 2+ 3+  
PDPNTLCDEFK seph(7) 51.26 2+ 3+  
PLALVYGEATSR 42.22 2+  
PLALVYGEATSRR 13.21 2+ 3+  
PLAQSHATK 23.47 2+  
PTPEGDLEILLQK 60.75 3+ 2+  
PTPEGDLEILLQKWENGECAQKK 6.92 3+  
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PVNTFVHESLADVQAVCSQK seph(17) 73.83 3+  
PVSQSAIIMTCPDCPSTSPYDLSNPR 55.15 3+  
PVSQSAIIMTCPDCPSTSPYDLSNPR OxiM(9) 50.79 3+  
PVSQSAIIMTCPDCPSTSPYDLSNPR seph(11) seph(14) 7.05 3+  
QEPERNECFLSHK seph(8) 44.8 3+  
QEPERNECFLSHKDDSPDLPK seph(8) 46.27 3+  
QHMDSSTSAASSSNYCNQMMK 36.74 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(19) 29.82 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(19) OxiM(20) 24.35 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(20) 29.47 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(3) OxiM(19) 27.25 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(3) OxiM(19) 
OxiM(20) 22.04 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(3) OxiM(20) 29.06 3+  
QHMDSSTSAASSSNYCNQMMK seph(16) OxiM(19) 
OxiM(20) 45.42 3+  
QHMDSSTSAASSSNYCNQMMKSR OxiM(20) 88.34 3+  
QHMDSSTSAASSSNYCNQMMKSR seph(16) OxiM(20) 36.1 3+  
QNCDQFEK 42.94 2+  
QNCDQFEK seph(3) 43.82 2+  
QNCDQFEKLGEYGFQNALIVR seph(3) 67.68 3+  
QSPVDIDTK 29.64 2+ 1+  
QSPVDIDTKAVVQDPALK 49.16 3+  
QTALVELLK 52.74 1+ 2+  
QTALVELLKHK 2.19 2+  
QVRGFPK 22.61 2+  
RHGLDNYR 40.6 2+  
RHPEYAVSVLLR 42.09 3+ 2+  
RHPEYAVSVLLRLAK 40.29 3+  
RHPYFYAPELLYYANK 54.12 3+ 2+  
RMVNNGHSFNVEYDDSQDK 33.82 3+  
RMVNNGHSFNVEYDDSQDKAVLK 7.19 3+  
RPCFSALTPDETYVPK 1.66 3+  
RPCFSALTPDETYVPK seph(3) 58.14 3+ 2+  
SAECPGPAQK 14.25 2+  
SAECPGPAQK seph(4) 26.24 2+  
SAECPGPAQKGYPFILPS seph(4) 8.71 3+  
SEIAHRFK 70.69 2+  
SHCIAEVEK 21.32 2+  
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SHCIAEVEK seph(3) 29.09 2+  
SLGKVGTRCCTK 12.75 2+  
SLGKVGTRCCTK seph(10) 85.78 3+  
SLHTLFGDELCK 4.42 2+  
SLHTLFGDELCK seph(11) 65 2+ 3+ 1+  
SLHTLFGDELCKVASLR seph(11) 71.51 3+  
TCVADESHAGCEK 51.39 3+  
TCVADESHAGCEK seph(11) 41.75 3+  
TCVADESHAGCEK seph(2) seph(11) 55.69 2+ 3+  
TCVADESHAGCEKSLHTLFGDELCK seph(24) 9.28 3+  
TEELQQQNTAPTNSPTK 64.96 3+  
TEREDLIAYLK 47.42 2+ 3+  
TEREDLIAYLKK 43.15 3+  
TGPNLHGLFGR 44.2 2+ 1+  
TGQAPGFTYTDANK 32.05 2+ 1+  
TGQAPGFTYTDANKNK 28.77 3+  
TKIPAVFK 35.84 2+  
TKIPAVFKIDALNENK 47.46 3+  
TLNFNAEGEPELLMLANWR 70.78 2+ 3+  
TLNFNAEGEPELLMLANWR OxiM(14) 67.12 2+ 3+  
TLNFNAEGEPELLMLANWRPAQPLK 67.52 3+  
TLNFNAEGEPELLMLANWRPAQPLK OxiM(14) 65.36 3+  
TLNFNAEGEPELLMLANWRPAQPLKNR 65.2 3+  
TPEVDDEALEK 30.97 2+ 1+  
TPEVDDEALEKFDK 42.29 2+ 3+  
TPEVDDEALEKFDKALK 48.32 3+  
TPVSEKVTK 28.15 2+  
TPVSEKVTKCCTESLVNR 64.87 3+  
TTQANKHIIVACEGNPYVPVHFDASV seph(12) 64.88 3+ 2+  
TVMENFVAFVDK 61.38 2+ 1+  
TVMENFVAFVDK OxiM(3) 34.56 2+ 3+  
TVMENFVAFVDKCCAADDK OxiM(3) 53.79 3+  
TVMENFVAFVDKCCAADDKEACFAVEGPK seph(14) 77.54 3+  
VAGTWYSLAMAASDISLLDAQSAPLR 77.24 2+ 3+  
VAGTWYSLAMAASDISLLDAQSAPLR OxiM(10) 73.4 2+ 3+  
VCMIDDTLDDDLFK seph(2) 62.21 3+  
VEADIAGHGQEVLIR 38.68 3+ 1+ 2+  
VFGRCELAAAMK 48.01 3+  
VFGRCELAAAMK OxiM(11) 20.22 3+  
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VFGRCELAAAMK seph(5) OxiM(11) 25.1 3+  
VFGRCELAAAMKR 37.63 3+  
VFGRCELAAAMKR seph(5) 62.39 3+  
VGDANPALQK 21.96 1+ 2+  
VGDANPALQKVLDALDSIK 69.71 2+ 3+  
VGDANPALQKVLDALDSIKTK 64.41 3+  
VGINYWLAHK 45.14 2+ 3+ 1+  
VGINYWLAHKALCSEK 87.96 2+  
VGTRCCTK 26.4 2+  
VGTRCCTK seph(6) 29.55 2+  
VGTRCCTKPESER seph(6) 48.57 3+  
VHKECCHGDLLECADDR 30.92 3+  
VHKECCHGDLLECADDR seph(13) 50.74 3+  
VHKECCHGDLLECADDR seph(5) 46.23 3+  
VHKECCHGDLLECADDR seph(5) seph(6) seph(13) 65.3 3+  
VLASSARQRLR 86.39 2+  
VLDALDSIK 42.91 2+ 1+  
VLDALDSIKTK 39.24 2+ 3+  
VLDALDSIKTKGK 35.36 3+  
VLVLDTDYK 41.16 2+ 1+  
VLVLDTDYKK 35.84 2+  
VPQVSTPTLVEVSR 44.8 2+  
VTKCCTESLVNR 23.26 3+  
VTKCCTESLVNR seph(4) 42.21 3+  
VTKCCTESLVNR seph(4) seph(5) 26.31 3+  
VTKCCTESLVNRR seph(4) 47.13 3+  
VVVLPFPSK 48.79 2+  
VYVEELK 32.62 2+  
VYVEELKPTPEGDLEILLQK 72.5 3+ 2+  
WENDECAQK 26.55 2+  
WENDECAQK seph(6) 44.63 2+  
WENDECAQKK 44.27 3+  
WENGECAQKK seph(6) 18.6 3+  
WWCNDGR seph(3) 61.81 2+  
WWCNDGRTPGSR seph(3) 56.15 3+  
YAAELHLVHWNTK 42.62 2+ 3+  
YGDFGTAAQQPDGLAVVGVFLK 67.43 2+ 3+  
YGDFGTAAQQPDGLAVVGVFLKVGDANPALQK 70.5 3+  
YICDNQDTISSK 28.08 3+ 2+  
 73 
Table 2.4 (continued) 
YICDNQDTISSK seph(3) 50.47 2+ 1+  
YICDNQDTISSKLK 14.48 3+  
YICDNQDTISSKLK seph(3) 92.47 2+  
YIPGTK 20.41 1+  
YIPGTKMIFAGIKK OxiM(7) 28.19 3+  
YKELGFQG 35.65 2+  
YLEFISDAIIHVLHSK 72.01 2+ 3+  
YLLFCMENSAEPEQSLVCQCLVR seph(5) seph(18) 
seph(20) 91.46 3+  
YLYEIAR 39.59 1+ 2+  
YLYEIARR 34.88 2+  
YNGVFQECCQAEDK 41.16 2+  
YNGVFQECCQAEDK seph(8) seph(9) 75.38 2+  
YNGVFQECCQAEDKGACLLPK seph(17) 64.12 3+  
YPNCAYK seph(4) 46.43 2+  
YTRKVPQVSTPTLVEVSR 39.47 3+  
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Table 2.5. All identified peptides for the protein mixture (Figure 2.8b) from cysteine 
filtered HCD MassMatrix Search algorithm and their corresponding charge 
states and retention times.  (Note: seph(residuenumber) is representative of 
an addition of SePh). 
Peptide + Modification 
Retention Time 
(Minutes) 
Charge 
State 
ALCSEK seph(3) 40.23 2+ 1+  
ALCSEKLDQWLCEKL seph(3) 52.36 3+  
ALPMHIRLSFNPTQLEEQCHI seph(19) 0.13 3+  
CAQCHTVEK seph(1) 58.18 2+  
CAQCHTVEK seph(1) seph(4) 57.33 2+ 3+  
CAQCHTVEK seph(4) 40.6 2+  
CAQCHTVEKGGK seph(1) 81.05 3+ 2+  
CAQCHTVEKGGK seph(1) seph(4) 38.36 2+  
CAQCHTVEKGGK seph(4) 52.69 3+  
CAQCHTVEKGGKHK seph(1) 92.37 3+  
CAQCHTVEKGGKHK seph(4) 57.05 3+  
CASIQK seph(1) 40.49 2+ 1+  
CASIQKFGER seph(1) 50 3+ 2+  
CASIQKFGERALK seph(1) 79.28 2+  
CCAADDK seph(1) 22.37 2+  
CCAADDK seph(1) seph(2) 70.32 2+  
CCAADDK seph(2) 39.88 2+  
CCAADDKEACFAVEGPK seph(1) 55.61 3+ 2+  
CCAADDKEACFAVEGPK seph(1) seph(2) seph(10) 78.74 3+  
CCAADDKEACFAVEGPK seph(10) 59.36 3+ 2+  
CCAADDKEACFAVEGPK seph(2) 45.34 2+ 3+  
CCTESLVNR seph(1) 58.6 2+  
CCTESLVNR seph(1) seph(2) 78.49 2+  
CCTESLVNR seph(2) 9.1 2+  
CCTESLVNRR seph(1) 51.32 3+ 2+  
CCTESLVNRR seph(2) 83.43 3+  
CCTKPESER seph(1) 58.44 2+  
CCTKPESER seph(1) seph(2) 76.93 2+  
CDTISMTSYSQYCNTQGNK seph(1) OxiM(6) seph(13) 88.07 3+  
CELAAAMK seph(1) 60.07 2+ 1+  
CELAAAMK seph(1) OxiM(7) 29.69 2+ 1+  
CELAAAMKR seph(1) 51.66 2+  
CELAAAMKR seph(1) OxiM(7) 28.78 1+ 2+  
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CEVFRELK seph(1) 47.32 2+  
CEVFRELKDLK seph(1) 20.21 2+ 3+  
CKGTDVQAWIR seph(1) 59.85 2+ 3+  
CKPVNTFVHESLADVQAVCSQK seph(1) seph(19) 82.45 3+  
DAIPENLPPLTADFAEDKDVCK seph(21) 72.45 3+ 2+  
DDPHACYSTVFDK seph(6) 62.18 3+ 2+  
DDPHACYSTVFDKLK seph(6) 55.73 3+  
DDQNPHSSNICNISCDK seph(11) seph(15) 75.39 3+ 2+  
DDQNPHSSNICNISCDK seph(15) 64.04 2+  
DVCKNYQEAK seph(3) 27.83 2+  
EACFAVEGPK seph(3) 35.62 2+ 3+  
ECCDKPLLEK seph(2) 52.11 2+  
ECCDKPLLEK seph(2) seph(3) 70.18 2+ 3+  
ECCDKPLLEK seph(3) 44.88 3+ 2+  
ECCHGDLLECADDR seph(10) 63.31 3+  
ECCHGDLLECADDR seph(2) 60.95 3+ 2+  
ECCHGDLLECADDR seph(2) seph(10) 73.96 3+  
ECCHGDLLECADDR seph(2) seph(3) 66.36 3+  
ECCHGDLLECADDR seph(3) 76.66 3+ 2+  
ECCHGDLLECADDR seph(3) seph(10) 31.41 3+  
EQLTKCEVFR seph(6) 71.28 3+ 2+  
EQLTKCEVFRELK seph(6) 54.94 3+  
EQRSAECPGPAQK seph(7) 92.68 3+  
ESPCVK seph(4) 50.49 2+  
ETYGDMADCCEK OxiM(6) seph(10) 41.91 2+  
ETYGDMADCCEK OxiM(6) seph(9) seph(10) 34.1 3+  
ETYGDMADCCEK seph(10) 75.99 2+ 3+  
EYEATLEECCAK seph(10) 43.75 3+  
EYEATLEECCAK seph(9) seph(10) 60.43 2+ 3+  
FLDDDLTDDIMCVK OxiM(11) seph(12) 72.28 3+ 2+  
FLDDDLTDDIMCVK seph(12) 76.65 2+  
GACLLPK seph(3) 62.13 1+ 2+  
GACLLPKIETMR seph(3) 78.9 2+  
GACLLPKIETMR seph(3) OxiM(11) 20.07 3+  
GACLLPKIETMREK seph(3) 62.8 3+  
GTDVQAWIRGCR seph(11) 40.73 3+ 2+  
GTDVQAWIRGCRL seph(11) 77.11 3+ 2+  
GYSLGNWVCAAK seph(9) 72.91 3+ 2+ 1+  
HIIVACEGNPYVPVHFDASV seph(6) 73.05 3+ 2+  
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HLVDEPQNLIKQNCDQFEK seph(14) 65.07 3+  
IFHESVYGQCK seph(10) 53.41 3+ 2+  
IFVQKCAQCHTVEK seph(6) 64.24 3+ 2+  
IFVQKCAQCHTVEK seph(9) 70.58 3+ 2+  
IFVQKCAQCHTVEKGGK seph(6) seph(9) 70.61 2+  
KQACEGNEWK seph(4) 32.55 2+  
KVFGRCELAAAMK seph(6) 58.75 3+  
KVFGRCELAAAMK seph(6) OxiM(12) 53.31 3+  
LAKEYEATLEECCAK seph(13) 56.11 3+  
LCVLHEK seph(2) 76.38 2+  
LCVLHEKTPVSEK seph(2) 50.1 2+ 3+  
LDQWLCEK seph(6) 66.72 2+ 1+  
LFTFHADICTLPDTEK seph(9) 76.24 3+  
LKECCDK seph(4) 48.57 2+  
LKECCDK seph(4) seph(5) 36.14 2+  
LKECCDK seph(5) 40.19 2+  
LKECCDKPLLEK seph(4) seph(5) 65.41 3+ 2+  
LKECCDKPLLEK seph(5) 68.16 3+  
LKPDPNTLCDEFK seph(9) 69.15 3+ 2+  
LKPDPNTLCDEFKADEK seph(9) 64.6 3+ 2+  
LRCASIQK seph(3) 22.97 2+  
LSFNPTQLEEQCHI seph(12) 80.14 2+ 3+ 1+  
LTCNYAPLYFIRKEK seph(3) 21.2 3+  
MPCTEDYLSLILNR OxiM(1) seph(3) 78.59 3+ 2+  
MPCTEDYLSLILNR seph(3) 82.29 3+ 2+  
NECFLSHK seph(3) 78.63 2+  
NECFLSHKDDSPDLPK seph(3) 55.95 3+  
NLCNIPCSALLSSDITASVNCAK seph(21) 78.16 3+ 2+  
NLCNIPCSALLSSDITASVNCAK seph(3) 79.83 2+ 3+  
NLTKDRCK seph(7) 45.1 2+  
NRCKGTDVQAWIR seph(3) 54.98 3+  
PCFSALTPDETYVPK seph(2) 7.3 3+ 2+  
PDPNTLCDEFK seph(7) 56.7 2+ 3+  
PLLEKSHCIAEVEK seph(8) 74.17 3+ 2+  
PVNTFVHESLADVQAVCSQK seph(17) 80.91 3+  
QACEGNEWK seph(3) 91.33 2+  
QAPGPCEASRQEK seph(6) 47.97 3+  
QEPERNECFLSHK seph(8) 52.35 3+  
QHMDSSTSAASSSNYCNQMMK seph(16) 34.79 3+  
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QHMDSSTSAASSSNYCNQMMK seph(16) OxiM(19) 
OxiM(20) 51.92 3+  
QNCDQFEK seph(3) 25.67 2+  
QNCDQFEKLGEYGFQNALIVR seph(3) 74.17 3+  
QRLRCASIQK seph(5) 70.99 3+ 2+  
RPCFSALTPDETYVPK seph(3) 64.48 3+ 2+  
SAECPGPAQK seph(4) 46.87 2+  
SHCIAEVEK seph(3) 46.38 2+  
SLGKVGTRCCTK seph(10) 53.31 2+ 3+  
SLGKVGTRCCTK seph(9) 42.53 3+  
SLGKVGTRCCTK seph(9) seph(10) 48.3 3+  
SLHTLFGDELCK seph(11) 72.22 3+ 2+  
SLHTLFGDELCKVASLR seph(11) 62.42 3+  
TCVADESHAGCEK seph(11) 37.12 3+  
TCVADESHAGCEK seph(2) seph(11) 55.81 3+ 2+  
TTQANKHIIVACEGNPYVPVHFDASV seph(12) 72.15 3+  
TVMENFVAFVDKCCAADDK OxiM(3) seph(14) 76.54 3+  
VFGRCELAAAMK seph(5) 39.06 2+ 3+  
VFGRCELAAAMK seph(5) OxiM(11) 52.35 3+ 2+  
VFGRCELAAAMKR seph(5) 17.82 2+  
VFGRCELAAAMKR seph(5) OxiM(11) 8.39 3+ 2+  
VGTRCCTK seph(5) 36.84 2+  
VGTRCCTK seph(6) 33.59 2+  
VGTRCCTKPESER seph(5) 23.2 3+  
VHKECCHGDLLECADDR seph(13) 56.1 3+  
VTKCCTESLVNR seph(4) seph(5) 52.45 3+  
VTKCCTESLVNRR seph(4) 51.63 3+  
VYVEELKPTPEGDLEILLQKWENGECAQK seph(26) 71.28 3+  
WENDECAQK seph(6) 53.98 2+ 3+  
WENGECAQK seph(6) 54.07 2+ 3+  
WENGECAQKK seph(6) 24.22 3+  
WENGECAQKKIIAEK seph(6) 36.62 3+  
WWCNDGR seph(3) 83.27 2+  
WWCNDGRTPGSR seph(3) 63.4 3+ 2+  
YACNPYK seph(3) 33.52 2+  
YACNPYKSSGTER seph(3) 21.01 3+  
YICDNQDTISSK seph(3) 57.68 2+  
YNGVFQECCQAEDK seph(8) 72.22 3+  
YNGVFQECCQAEDK seph(8) seph(9) 82.16 2+  
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YNGVFQECCQAEDK seph(9) 60.48 3+ 2+  
YNGVFQECCQAEDKGACLLPK seph(9) seph(17) 75.71 3+  
YPNCAYK seph(4) 71.4 2+ 1+  
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Table 2.6. All identified peptides for the protein mixture (Figure 2.8b) from full 
database HCD MassMatrix Search algorithm and their corresponding 
charge states and retention times.  (Note: seph(residuenumber) is 
representative of an addition of SePh). 
Peptide + Modification 
Retention 
Time 
(Min) Charge 
ADEKKFWGK 71.37 2+  
AEFVEVTK 37.75 1+ 2+  
AEFVEVTKLVTDLTK 70.03 2+ 3+  
AEFVEVTKLVTDLTKVHK 65.27 3+  
AIFYINK 44.69 1+ 2+  
AIFYINKEK 91.48 2+  
AIFYINKEKR 36.28 2+  
ALCSEK 37.6 1+  
ALCSEK seph(3) 53.26 1+ 2+  
ALCSEKLDQWLCEKL seph(3) 52.36 3+  
ALELFR 51.45 1+  
ALELFRNDIAAK 51.36 2+ 3+  
ALELFRNDIAAKYK 48.73 2+  
ALKALPMHIR 26.19 2+  
ALKALPMHIR OxiM(7) 84.8 2+  
ALKAWSVAR 52.51 2+  
ALKAWSVARLSQK 46.93 2+  
ALPMHIR 38.34 2+  
ALPMHIR OxiM(4) 83.27 2+  
ALPMHIRLSFNPTQLEEQCHI seph(19) 0.13 3+  
ASEDLKK 46.51 1+  
ATEEQLK 54.07 2+  
ATEEQLKTVMENFVAFVDK 79.34 3+  
ATEEQLKTVMENFVAFVDK OxiM(10) 67.24 3+  
AVLKDGPLTGTYR 41.94 2+ 3+  
AVVQDPALK 33.94 2+  
AVVQDPALKPLALVYGEATSR 67.05 3+  
AVVQDPALKPLALVYGEATSRR 78.42 3+  
AWSVAR 34.57 1+  
AWSVARLSQK 45.66 2+  
CAQCHTVEK 26.87 1+ 2+  
CAQCHTVEK seph(1) 48.64 2+  
 80 
Table 2.6 (continued) 
CAQCHTVEK seph(1) seph(4) 55.99 2+ 3+  
CAQCHTVEK seph(4) 41.2 2+  
CAQCHTVEKGGK 43.33 2+ 3+  
CAQCHTVEKGGK seph(1) 28.2 3+  
CAQCHTVEKGGK seph(1) seph(4) 37.66 2+  
CAQCHTVEKGGK seph(4) 52.69 3+  
CAQCHTVEKGGKHK 26.34 2+ 3+  
CAQCHTVEKGGKHK seph(1) 84.33 3+  
CAQCHTVEKGGKHK seph(4) 39.16 3+  
CASIQK 49.16 1+  
CASIQK seph(1) 24.21 1+ 2+  
CASIQKFGER 40.75 2+  
CASIQKFGER seph(1) 25.13 2+ 3+  
CASIQKFGERALK 26.04 3+  
CASIQKFGERALK seph(1) 79.28 2+  
CCAADDK seph(1) 83.43 2+  
CCAADDK seph(1) seph(2) 27.3 2+  
CCAADDK seph(2) 39.88 2+  
CCAADDKEACFAVEGPK seph(1) 55.8 2+ 3+  
CCAADDKEACFAVEGPK seph(1) seph(2) seph(10) 78.74 3+  
CCAADDKEACFAVEGPK seph(10) 59.22 2+ 3+  
CCAADDKEACFAVEGPK seph(2) 45.34 2+ 3+  
CCTESLVNR 36.14 2+  
CCTESLVNR seph(1) 71.27 2+  
CCTESLVNR seph(1) seph(2) 71.76 2+  
CCTESLVNR seph(2) 9.1 2+  
CCTESLVNRR 31.56 2+  
CCTESLVNRR seph(1) 45.91 2+ 3+  
CCTESLVNRR seph(2) 83.43 3+  
CCTKPESER 18.12 2+  
CCTKPESER seph(1) 58.44 2+  
CCTKPESER seph(1) seph(2) 76.93 2+  
CELAAAMK 37.27 1+ 2+  
CELAAAMK OxiM(7) 44.98 1+ 2+  
CELAAAMK seph(1) 59.61 1+ 2+  
CELAAAMK seph(1) OxiM(7) 50.63 1+ 2+  
CELAAAMKR 49.61 2+  
CELAAAMKR OxiM(7) 37.27 2+  
CELAAAMKR seph(1) 50.54 2+  
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CELAAAMKR seph(1) OxiM(7) 46.84 2+  
CEVFRELK 21.51 2+  
CEVFRELK seph(1) 49.9 2+  
CEVFRELKDLK 24.35 2+ 3+  
CEVFRELKDLK seph(1) 20.21 2+ 3+  
CKGTDVQAWIR 35.25 2+ 3+  
CKGTDVQAWIR seph(1) 59.22 2+ 3+  
CKGTDVQAWIRGCR 56.36 3+  
CKPVNTFVHESLADVQAVCSQK seph(1) seph(19) 82.45 3+  
DAFLGSFLYEYSR 71.74 2+ 3+  
DAFLGSFLYEYSRR 82.69 2+  
DAIPENLPPLTADFAEDK 42.35 2+ 3+  
DAIPENLPPLTADFAEDKDVCK seph(21) 72.5 2+ 3+  
DDPHACYSTVFDK 62.27 3+  
DDPHACYSTVFDK seph(6) 44.78 2+ 3+  
DDPHACYSTVFDKLK seph(6) 55.73 3+  
DDQNPHSSNICNISCDK 34.17 2+ 3+  
DDQNPHSSNICNISCDK seph(11) seph(15) 75.3 2+ 3+  
DDQNPHSSNICNISCDK seph(15) 64.04 2+  
DDSPDLPK 83.19 1+ 2+  
DDSPDLPKLK 84.48 2+  
DFPIANGER 72.96 1+ 2+  
DGPLTGTYR 51.49 1+ 2+  
DGYVLSLNR 47.71 2+  
DLGEEHFK 37.75 2+  
DRKDGYVLSLNR 63.02 2+  
DTHKSEIAHR 49.68 2+  
DVCKNYQEAK 71.28 2+  
DVCKNYQEAK seph(3) 66.96 2+  
EACFAVEGPK 18.27 2+  
EACFAVEGPK seph(3) 36.09 2+ 3+  
ECCDKPLLEK 35.63 2+  
ECCDKPLLEK seph(2) 53.16 2+  
ECCDKPLLEK seph(2) seph(3) 70.18 2+ 3+  
ECCDKPLLEK seph(3) 62.98 2+ 3+  
ECCHGDLLECADDR 51.26 3+  
ECCHGDLLECADDR seph(10) 63.31 3+  
ECCHGDLLECADDR seph(2) 33.66 2+ 3+  
ECCHGDLLECADDR seph(2) seph(10) 73.96 3+  
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ECCHGDLLECADDR seph(2) seph(3) 66.36 3+  
ECCHGDLLECADDR seph(3) 60.95 2+ 3+  
ECCHGDLLECADDR seph(3) seph(10) 31.43 3+  
EDLIAYLK 60.62 1+ 2+  
EDLIAYLKK 56.05 2+  
EDLIAYLKKATNE 55.95 3+  
EETLMEYLENPK 41.7 2+ 3+  
EETLMEYLENPK OxiM(5) 37.85 1+ 2+ 3+  
EETLMEYLENPKK 17.59 2+ 3+  
EETLMEYLENPKK OxiM(5) 27.33 2+ 3+  
EGSQEK 35.59 1+  
EKRIFYLPAYNCTLR 58.45 3+  
EKVLASSAR 38.34 2+  
EKVLASSARQR 39.29 1+ 2+ 3+  
ELGFQG 42.05 1+  
EPISVSSQQMLK 28.95 2+ 3+  
EPISVSSQQMLK OxiM(10) 59.85 2+ 3+  
EQLTKCEVFR 38.34 2+ 3+  
EQLTKCEVFR seph(6) 28.83 2+ 3+  
EQLTKCEVFRELK 59.47 3+  
EQLTKCEVFRELK seph(6) 54.94 3+  
EQRSAECPGPAQK 61.7 2+ 3+  
EQRSAECPGPAQK seph(7) 17.27 3+  
ESPCVK seph(4) 49.07 2+  
ETAAAK 17.2 1+  
ETAAAKFER 24.07 2+  
ETGSSK 57.18 1+  
ETGSSKYPNCAYK 83.86 3+  
ETYGDMADCCEK 40.65 2+  
ETYGDMADCCEK OxiM(6) 30.78 2+  
ETYGDMADCCEK OxiM(6) seph(10) 41.9 2+  
ETYGDMADCCEK OxiM(6) seph(9) seph(10) 22.26 3+  
ETYGDMADCCEK seph(10) 75.99 2+ 3+  
ETYGDMADCCEKQEPER 39.75 3+  
ETYGDMADCCEKQEPER OxiM(6) 27.83 3+  
EYEATLEECCAK 43.67 2+  
EYEATLEECCAK seph(10) 43.75 3+  
EYEATLEECCAK seph(9) seph(10) 60.43 2+ 3+  
FDKALK 57.08 1+  
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FDKALKALPMHIR OxiM(10) 55.62 3+  
FDKFKHLK 21.2 2+  
FERQHMDSSTSAASSSNYCNQMMK OxiM(22) OxiM(23) 36.53 3+  
FESNFNTQATNR 37.22 2+ 3+  
FESNFNTQATNRNTDGSTDYGILQINSR 54.07 3+  
FGERALK 54.21 1+ 2+  
FGERALKAWSVAR 39.86 3+  
FKDLGEEHFK 36.54 2+ 3+  
FKHLKTEAEMK 51.44 2+ 3+  
FLDDDLTDDIMCVK 53.02 2+  
FLDDDLTDDIMCVK OxiM(11) 64.9 2+  
FLDDDLTDDIMCVK OxiM(11) seph(12) 45.23 2+ 3+  
FLDDDLTDDIMCVK seph(12) 77.27 2+  
FLDDDLTDDIMCVKK 19.99 2+ 3+  
FLDDDLTDDIMCVKK OxiM(11) 68.87 2+  
FMETATESLAK 51.77 2+ 3+  
FMETATESLAK OxiM(2) 92.56 2+ 3+  
FMETATESLAKYNSESPSKQYSLVK OxiM(2) 10.96 3+  
FPKAEFVEVTK 56.89 3+  
FWGKYLYEIAR 57.22 2+  
FWGKYLYEIARR 23.51 3+  
GACLLPK seph(3) 83.12 1+ 2+  
GACLLPKIETMR 31.85 2+ 3+  
GACLLPKIETMR OxiM(11) 27.03 2+  
GACLLPKIETMR seph(3) 78.9 2+  
GACLLPKIETMR seph(3) OxiM(11) 56.33 3+  
GACLLPKIETMREK 22.42 2+ 3+  
GACLLPKIETMREK OxiM(11) 19.61 2+ 3+  
GACLLPKIETMREK seph(3) 62.8 3+  
GDVEKGKK 36.35 2+  
GENATVNQR 59.42 2+  
GHHEAELK 34.22 2+  
GHHEAELKPLAQSHATK 26.25 3+  
GKKIFVQK 76.77 1+ 2+  
GLDIQK 32.65 1+  
GLSDGEWQQVLNVWGK 71.66 2+ 3+  
GSVQYLPDWDK 56.42 2+ 3+  
GSVQYLPDWDKKR 47.59 3+  
GTDVQAWIR 48.54 1+ 2+  
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GTDVQAWIRGCR 67.43 2+ 3+  
GTDVQAWIRGCR seph(11) 80.53 2+ 3+  
GTDVQAWIRGCRL 54.27 2+ 3+  
GTDVQAWIRGCRL seph(11) 77.9 2+ 3+  
GYPFILPS 64.38 1+  
GYSLGNWVCAAK 32.29 2+ 3+  
GYSLGNWVCAAK seph(9) 34.52 1+ 2+ 3+  
HGLDNYR 83.79 2+  
HGTVVLTALGGILK 63.02 2+ 3+  
HGTVVLTALGGILKK 59.22 2+ 3+  
HIIVACEGNPYVPVHFDASV seph(6) 73.15 2+ 3+  
HKPKATEEQLK 19.27 2+ 3+  
HKTGPNLHGLFGR 81.14 2+ 3+  
HKTGPNLHGLFGRK 91.61 3+  
HLKTEAEMK 38.69 2+  
HLKTEAEMK OxiM(8) 60.67 2+  
HLVDEPQNLIK 43.57 2+ 3+  
HLVDEPQNLIKQNCDQFEK seph(14) 65.07 3+  
HPEYAVSVLLR 31.85 2+ 3+  
HPGDFGADAQGAMTK 29.62 2+ 3+  
HPGDFGADAQGAMTK OxiM(13) 31.93 2+ 3+  
HPYFYAPELLYYANK 63.73 2+ 3+  
IDALNENK 36 1+ 2+  
IDALNENKVLVLDTDYK 54.89 3+  
IDALNENKVLVLDTDYKK 50.78 3+  
IETMREK 28.2 2+  
IETMREKVLASSAR 70.21 3+  
IFHESVYGQCK 56.33 2+ 3+  
IFHESVYGQCK seph(10) 53.55 2+ 3+  
IFVQKCAQCHTVEK 33.93 3+  
IFVQKCAQCHTVEK seph(6) 66.23 2+ 3+  
IFVQKCAQCHTVEK seph(9) 91.34 2+ 3+  
IFVQKCAQCHTVEKGGK seph(6) seph(9) 70.61 2+  
IFYLPAYNCTLR 59.75 3+  
IIAEKTK 85.02 2+  
IIAEKTKIPAVFK 40.8 2+  
ILDKVGINYWLAHK 56.7 2+ 3+  
IPAVFK 42.91 1+  
IPAVFKIDALNENK 55.86 2+ 3+  
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IVSDGNGMNAWVAWR 61.54 2+  
IVSDGNGMNAWVAWR OxiM(8) 51.3 2+  
IVSDGNGMNAWVAWRNR 54.79 3+  
KDGYVLSLNR 29.61 2+  
KDGYVLSLNRVSDAR 71.52 3+  
KETAAAKFER 41 2+  
KGHHEAELK 20.28 1+ 2+  
KGHHEAELKPLAQSHATK 91.43 3+  
KHGTVVLTALGGILK 50.73 2+ 3+  
KIFVQK 49.56 1+  
KIFVQKCAQCHTVEK 66.12 3+  
KIIAEKTK 24.96 2+  
KILDKVGINYWLAHK 67.85 3+  
KIVSDGNGMNAWVAWR 53.56 2+ 3+  
KIVSDGNGMNAWVAWR OxiM(9) 47.47 2+ 3+  
KIVSDGNGMNAWVAWRNR OxiM(9) 33.2 3+  
KKGHHEAELK 38.69 2+  
KQTALVELLK 84.33 1+ 2+  
KREGSQEK 23.37 2+  
KTEREDLIAYLK 37.56 2+ 3+  
KTGQAPGFTYTDANK 31.29 2+ 3+  
KTGQAPGFTYTDANKNK 32.82 3+  
KVFGRCELAAAMK 26.73 2+ 3+  
KVFGRCELAAAMK OxiM(12) 35.41 2+ 3+  
KVFGRCELAAAMK seph(6) 58.75 3+  
KVFGRCELAAAMK seph(6) OxiM(12) 53.31 3+  
KVPQVSTPTLVEVSR 51.26 2+ 3+  
KYAAELHLVHWNTK 45.61 3+  
KYIPGTK 29.5 2+  
KYIPGTKMIFAGIK 54.02 2+ 3+  
KYIPGTKMIFAGIK OxiM(8) 42.14 3+  
LAKEYEATLEECCAK seph(13) 56.11 3+  
LCVLHEK 27.75 2+  
LCVLHEK seph(2) 51.87 2+  
LCVLHEKTPVSEK 23.58 2+ 3+  
LCVLHEKTPVSEK seph(2) 62.75 2+  
LCVLHEKTPVSEKVTK 70.93 2+ 3+  
LDQWLCEK 77.42 2+  
LDQWLCEK seph(6) 65.7 1+ 2+  
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LFTFHADICTLPDTEK 62.12 3+  
LFTFHADICTLPDTEK seph(9) 76.35 3+  
LFTGHPETLEK 38.95 2+ 3+  
LFTGHPETLEKFDK 41.45 3+  
LFTGHPETLEKFDKFK 49 3+  
LGEYGFQNALIVR 59.42 2+ 3+  
LIVTQTMK 52.07 1+ 2+  
LIVTQTMK OxiM(7) 59.03 1+ 2+  
LIVTQTMKGLDIQK 50.94 3+  
LIVTQTMKGLDIQK OxiM(7) 64.27 2+ 3+  
LKECCDK 27.28 1+ 2+  
LKECCDK seph(4) 48.57 2+  
LKECCDK seph(4) seph(5) 36.14 2+  
LKECCDK seph(5) 71.11 2+  
LKECCDKPLLEK 33.22 2+ 3+  
LKECCDKPLLEK seph(4) seph(5) 65.14 2+ 3+  
LKECCDKPLLEK seph(5) 68.16 3+  
LKHLVDEPQNLIK 43.81 3+  
LKPDPNTLCDEFK 54.02 2+  
LKPDPNTLCDEFK seph(9) 70.31 2+ 3+  
LKPDPNTLCDEFKADEK seph(9) 64.28 2+ 3+  
LRCASIQK 51.88 2+  
LRCASIQK seph(3) 28.05 2+  
LSFNPTQLEEQCHI 69.65 2+  
LSFNPTQLEEQCHI seph(12) 79.79 1+ 2+ 3+  
LSQKFPK 26.39 2+  
LSQKFPKAEFVEVTK 45.23 2+ 3+  
LVNELTEFAK 80.15 1+ 2+  
LVQFHFHWGSSDDQGSEHTVDR 50.25 3+  
LVTDLTK 36.05 1+  
LVTDLTKVHK 55.66 2+  
LVVSTQTALA 25.66 1+ 2+  
MIFAGIK 49.56 1+  
MIFAGIK OxiM(1) 43.91 1+  
MIFAGIKK OxiM(1) 31.84 2+  
MIFAGIKKK 26.41 2+  
MIFAGIKKK OxiM(1) 52.79 1+  
MPCTEDYLSLILNR 76.76 2+ 3+  
MPCTEDYLSLILNR OxiM(1) 39.68 2+ 3+  
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Table 2.6 (continued) 
MPCTEDYLSLILNR OxiM(1) seph(3) 78.69 2+ 3+  
MPCTEDYLSLILNR seph(3) 82.67 2+ 3+  
MVNNGHSFNVEYDDSQDK 38.95 2+ 3+  
MVNNGHSFNVEYDDSQDK OxiM(1) 39.05 2+ 3+  
NDIAAKYKELGFQG 54.52 2+ 3+  
NECFLSHK 44.11 2+  
NECFLSHK seph(3) 55.93 2+  
NECFLSHKDDSPDLPK seph(3) 42.76 3+  
NECFLSHKDDSPDLPKLK 60.82 3+  
NKGITWK 33.54 2+  
NLCNIPCSALLSSDITASVNCAK seph(21) 78 2+ 3+  
NLCNIPCSALLSSDITASVNCAK seph(3) 79.83 2+ 3+  
NLTKDRCK 63.17 2+  
NLTKDRCK seph(7) 43.67 2+  
NRCKGTDVQAWIR 77.16 2+ 3+  
NRCKGTDVQAWIR seph(3) 54.98 3+  
NRQVRGFPK 86.9 1+ 2+  
NTDGSTDYGILQINSR 51.74 2+ 3+  
NYQEAKDAFLGSFLYEYSR 68.53 3+  
PAQPLKNR 46.14 2+  
PAQPLKNRQVR 26.3 2+  
PCFSALTPDETYVPK 71.88 2+  
PCFSALTPDETYVPK seph(2) 52.93 2+ 3+  
PDPNTLCDEFK 26.17 2+ 3+  
PDPNTLCDEFK seph(7) 56.7 2+ 3+  
PDPNTLCDEFKADEK 28.63 3+  
PKATEEQLK 28.05 2+  
PKATEEQLKTVMENFVAFVDK 58.66 3+  
PLALVYGEATSR 48.64 2+  
PLAQSHATK 23.82 2+  
PLAQSHATKHK 61.54 2+ 3+  
PLLEKSHCIAEVEK seph(8) 46.24 2+ 3+  
PTPEGDLEILLQK 33.38 2+ 3+  
PVNTFVHESLADVQAVCSQK seph(17) 80.71 3+  
QEPERNECFLSHK seph(8) 51.44 3+  
QHMDSSTSAASSSNYCNQMMK 34.9 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(19) 35.3 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(19) OxiM(20) 29.29 2+ 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(20) 34.05 3+  
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Table 2.6 (continued) 
QHMDSSTSAASSSNYCNQMMK OxiM(3) 24.13 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(3) OxiM(19) 33.32 3+  
QHMDSSTSAASSSNYCNQMMK OxiM(3) OxiM(19) OxiM(20) 27.76 3+  
QHMDSSTSAASSSNYCNQMMK seph(16) 34.79 3+  
QHMDSSTSAASSSNYCNQMMK seph(16) OxiM(19) OxiM(20) 51.59 3+  
QHMDSSTSAASSSNYCNQMMKSR OxiM(19) OxiM(20) 33.92 3+  
QIKKQTALVELLK 30.85 3+  
QNCDQFEK 31.93 2+  
QNCDQFEK seph(3) 29.3 2+  
QNCDQFEKLGEYGFQNALIVR seph(3) 74.17 3+  
QRLRCASIQK 41.6 2+ 3+  
QRLRCASIQK seph(5) 70.99 2+  
QSPVDIDTK 35.74 1+ 2+  
QSPVDIDTKAVVQDPALK 54.07 3+  
QTALVELLK 59.65 1+ 2+  
QTALVELLKHK 63.82 2+ 3+  
QTALVELLKHKPK 80.54 2+  
QVRGFPK 60.48 2+  
QYSLVKITK 21.36 2+  
REGSQEK 32.17 1+ 2+  
RHGLDNYR 56.95 2+  
RHPEYAVSVLLR 47.48 2+ 3+  
RHPEYAVSVLLRLAK 46.88 2+ 3+  
RHPYFYAPELLYYANK 74.36 2+ 3+  
RMVNNGHSFNVEYDDSQDKAVLK 38.29 3+  
RMVNNGHSFNVEYDDSQDKAVLK OxiM(2) 53.9 3+  
RPCFSALTPDETYVPK 55.42 3+  
RPCFSALTPDETYVPK seph(3) 66.09 2+ 3+  
SAECPGPAQK 48.9 2+  
SAECPGPAQK seph(4) 39.48 2+  
SEIAHR 43.72 1+  
SEIAHRFK 53.64 2+  
SHCIAEVEK 22.58 2+  
SHCIAEVEK seph(3) 46.24 2+  
SHHWGYGK 46.38 2+  
SLGKVGTR 43.91 2+  
SLGKVGTRCCTK 30.84 2+ 3+  
SLGKVGTRCCTK seph(10) 53.31 2+ 3+  
SLGKVGTRCCTK seph(9) 42.53 3+  
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SLGKVGTRCCTK seph(9) seph(10) 48.3 3+  
SLHTLFGDELCK 56.38 2+ 3+  
SLHTLFGDELCK seph(11) 75.01 2+ 3+  
SLHTLFGDELCKVASLR seph(11) 76.81 3+  
TCVADESHAGCEK 22.64 3+  
TCVADESHAGCEK seph(11) 37.12 3+  
TCVADESHAGCEK seph(2) seph(11) 55.8 2+ 3+  
TEAEMK 38.39 1+  
TEAEMKASEDLK 43.91 2+ 3+  
TEAEMKASEDLK OxiM(5) 72.3 2+  
TEAEMKASEDLKK 28.12 3+  
TEAEMKASEDLKK OxiM(5) 29.18 3+  
TEELQQQNTAPTNSPTK 47.23 3+  
TEREDLIAYLK 53.65 2+ 3+  
TGPNLHGLFGR 55.86 2+  
TGQAPGFTYTDANK 37.51 2+ 3+  
TGQAPGFTYTDANKNK 34.94 3+  
TKIPAVFK 53.65 2+  
TKIPAVFKIDALNENK 53.5 3+  
TLNFNAEGEPELLMLANWR 78.05 2+ 3+  
TLNFNAEGEPELLMLANWR OxiM(14) 75.25 2+ 3+  
TLNFNAEGEPELLMLANWRPAQPLK 73.8 3+  
TLNFNAEGEPELLMLANWRPAQPLK OxiM(14) 73.71 3+  
TLNFNAEGEPELLMLANWRPAQPLKNR OxiM(14) 77.96 3+  
TPEVDDEALEK 60.48 1+ 2+ 3+  
TPEVDDEALEKFDK 46.77 2+ 3+  
TPVSEKVTK 37.56 2+  
TSPPQPAAR 49.26 2+  
TSWKNCEVR 41.5 1+ 2+  
TTQANKHIIVACEGNPYVPVHFDASV seph(12) 72.15 3+  
TVMENFVAFVDK 68.04 2+ 3+  
TVMENFVAFVDK OxiM(3) 56.28 2+ 3+  
TVMENFVAFVDKCCAADDK OxiM(3) 59.99 3+  
TVMENFVAFVDKCCAADDK OxiM(3) seph(14) 76.54 3+  
VAGTWYSLAMAASDISLLDAQSAPLR 82.86 2+ 3+  
VAGTWYSLAMAASDISLLDAQSAPLR OxiM(10) 79.01 3+  
VEADIAGHGQEVLIR 44.4 2+ 3+  
VFGRCELAAAMK 54.73 3+  
VFGRCELAAAMK OxiM(11) 31.36 2+ 3+  
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VFGRCELAAAMK seph(5) 32.03 2+  
VFGRCELAAAMK seph(5) OxiM(11) 25.96 2+ 3+  
VFGRCELAAAMKR OxiM(11) 34.57 3+  
VFGRCELAAAMKR seph(5) 17.82 2+  
VFGRCELAAAMKR seph(5) OxiM(11) 36.05 2+ 3+  
VGDANPALQK 51.07 2+  
VGDANPALQKVLDALDSIK 75.86 2+ 3+  
VGDANPALQKVLDALDSIKTK 70.56 3+  
VGINYWLAHK 45.86 1+ 2+ 3+  
VGTRCCTK 42.81 1+ 2+  
VGTRCCTK seph(5) 35.74 2+  
VGTRCCTK seph(6) 33.59 2+  
VGTRCCTKPESER 50.03 2+  
VGTRCCTKPESER seph(5) 23.2 3+  
VHKECCHGDLLECADDR 35.87 3+  
VHKECCHGDLLECADDR seph(13) 55.37 3+  
VLASSARQR 49.63 2+  
VLASSARQRLR 25.06 2+ 3+  
VLDALDSIK 37.95 1+ 2+  
VLDALDSIKTK 27.4 2+ 3+  
VLDALDSIKTKGK 41.6 2+ 3+  
VLVLDTDYK 54.26 1+ 2+  
VLVLDTDYKK 59.61 2+  
VPQVSTPTLVEVSR 50.1 2+ 3+  
VSDAREHR 47.1 2+  
VTKCCTESLVNR seph(4) seph(5) 51.45 3+  
VTKCCTESLVNRR 47.38 2+  
VVVLPFPSK 50.77 1+ 2+  
VYVEELK 38.68 1+ 2+  
VYVEELKPTPEGDLEILLQK 68.09 2+ 3+  
VYVEELKPTPEGDLEILLQKWENGECAQK seph(26) 71.28 3+  
WENDECAQK 19.12 2+  
WENDECAQK seph(6) 50.3 2+  
WENDECAQKK 49.77 2+ 3+  
WENDECAQKKIIAEK 64.38 3+  
WENGECAQK 37.17 2+  
WENGECAQK seph(6) 39.06 2+ 3+  
WENGECAQKK 40.34 2+  
WENGECAQKK seph(6) 31.78 3+  
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WENGECAQKKIIAEK seph(6) 36.34 3+  
WWCNDGR seph(3) 40.6 2+  
WWCNDGRTPGSR 43.91 2+ 3+  
WWCNDGRTPGSR seph(3) 63.55 2+ 3+  
YAAELHLVHWNTK 48.68 2+ 3+  
YGDFGTAAQQPDGLAVVGVFLK 73.55 2+ 3+  
YICDNQDTISSK 33.15 2+  
YICDNQDTISSK seph(3) 61.21 2+  
YICDNQDTISSKLK 27.98 3+  
YIPGTK 51.54 1+  
YIPGTKMIFAGIKK 46.75 2+  
YKELGFQG 42.19 1+ 2+  
YLEFISDAIIHVLHSK 78.9 2+ 3+  
YLLFCMENSAEPEQSLACQCLVR 9.17 3+  
YLYEIAR 86.74 1+ 2+  
YLYEIARR 66.57 2+  
YNGVFQECCQAEDK 47.28 2+  
YNGVFQECCQAEDK seph(8) 72.22 3+  
YNGVFQECCQAEDK seph(8) seph(9) 82.16 2+  
YNGVFQECCQAEDK seph(9) 67.72 2+ 3+  
YNGVFQECCQAEDKGACLLPK seph(9) seph(17) 75.71 3+  
YNSESPSK 24.36 1+ 2+  
YPNCAYK 50.73 2+  
YPNCAYK seph(4) 53.85 2+  
YPNCAYKTTQANK 43.02 2+  
YPNCAYKTTQANK seph(4) 60.17 2+  
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Table 2.7. All identified peptides for the protein mixture (Figure 2.8b) from cysteine 
filtered UVPDnLossCID  CID MassMatrix Search algorithm and their 
corresponding charge states and retention times.  (Note: 
seph(residuenumber) is representative of an addition of SePh). 
Peptide + Modification 
Retention Time 
(Min) 
Charge 
States 
ALCSEK seph(3) 48.07 2+  
CAQCHTVEK seph(1) seph(4) 52.23 2+  
CCAADDKEACFAVEGPK seph(1) 51.9 3+  
CCAADDKEACFAVEGPK seph(10) 51.02 3+  
CCAADDKEACFAVEGPK seph(2) 49.62 3+  
CCTESLVNR seph(1) seph(2) 66.77 2+  
CELAAAMK seph(1) 53.98 2+  
CELAAAMK seph(1) OxiM(7) 46.5 2+  
CELAAAMKR seph(1) 49.98 2+  
CELAAAMKR seph(1) OxiM(7) 42.12 2+  
CGRIWAQVDTGKCR seph(1) 42.25 3+  
CKGTDVQAWIR seph(1) 54.45 2+ 3+  
DDAACCK seph(6) 51.75 2+  
DDPHACYSTVFDK seph(6) 56.65 2+ 3+  
EACFAVEGPK seph(3) 57.8 2+  
ECCDKPLLEK seph(2) seph(3) 64.7 3+  
ECCHGDLLECADDR seph(10) 57.88 3+  
ECCHGDLLECADDR seph(2) 54.65 3+  
ECCHGDLLECADDR seph(3) 54.6 3+  
ECCHGDLLECADDR seph(3) 
seph(10) 60.03 3+  
EYEATLEECCAK seph(9) seph(10) 48.82 3+  
FLDDDLTDDIMCVK OxiM(11) 
seph(12) 67.25 2+  
FLDDDLTDDIMCVK seph(12) 71.1 2+  
GACLLPK seph(3) 57.08 2+  
GGKEVTHCQACK seph(11) 70.77 2+  
GTDVQAWIRGCRL seph(11) 71.73 2+ 3+  
GYSLGNWVCAAK seph(9) 70.07 1+ 2+  
IFHESVYGQCK seph(10) 48.92 3+  
IFVQKCAQCHTVEK seph(6) 67.45 3+  
IFVQKCAQCHTVEK seph(9) 37.8 3+  
KMAAALECR OxiM(2) seph(8) 38.48 2+  
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KVFGRCELAAAMK seph(6) 54.68 3+  
LCVLHEK seph(2) 78.6 2+  
LCVLHEKTPVSEK seph(2) 43.88 3+  
LDQWLCEK seph(6) 61.95 1+ 2+  
LKECCDK seph(5) 55.48 2+  
LKECCDKPLLEK seph(4) seph(5) 63.95 2+ 3+  
LKPDPNTLCDEFK seph(9) 64.27 2+ 3+  
LRCASIQKFGER seph(3) 48.53 3+  
LSFNPTQLEEQCHI seph(12) 76.95 2+  
MPCTEDYLSLILNR OxiM(1) seph(3) 74.15 2+ 3+  
MPCTEDYLSLILNR seph(3) 77.87 2+ 3+  
NECFLSHK seph(3) 50.73 2+  
NECFLSHKDDSPDLPK seph(3) 52.1 3+  
NRCKGTDVQAWIR seph(3) 50.18 3+  
PCFSALTPDETYVPK seph(2) 65.57 2+  
PDPNTLCDEFK seph(7) 62.95 2+  
QEPERNECFLSHK seph(8) 46.78 3+  
QNCDQFEK seph(3) 45.37 2+  
RPCFSALTPDETYVPK seph(3) 59.85 2+ 3+  
SHCIAEVEK seph(3) 42.52 2+  
SLHTLFGDELCK seph(11) 69.77 2+ 3+  
TCVADESHAGCEK seph(2) seph(11) 49.33 2+ 3+  
VTKCCTESLVNRR seph(4) 46.03 3+  
WWCNDGRTPGSR seph(3) 54.93 3+  
YICDNQDTISSK seph(3) 52.72 2+  
YNGVFQECCQAEDK seph(8) 
seph(9) 76.98 2+  
YPNCAYK seph(4) 48.88 2+  
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Table 2.8. All identified peptides for the protein mixture (Figure 2.8b) from full 
database UVPDnLossCID CID MassMatrix Search algorithm and their 
corresponding charge states and retention times.  (Note: 
seph(residuenumber) is representative of an addition of SePh). 
Peptide + Modification 
Retention Time 
(Min) 
Charge 
State 
AEFVEVTKLVTDLTK 63.73 3+  
AIEYLYK 55.03 2+  
ALCSEK seph(3) 48.07 2+  
ALPMHIR 51.22 2+  
CAQCHTVEK seph(1) seph(4) 52.23 2+  
CCAADDKEACFAVEGPK seph(1) 51.9 3+  
CCAADDKEACFAVEGPK seph(10) 51.02 3+  
CCAADDKEACFAVEGPK seph(2) 49.62 3+  
CCTESLVNR seph(1) seph(2) 66.77 2+  
CELAAAMK 43.17 2+  
CELAAAMK seph(1) 53.98 2+  
CELAAAMK seph(1) OxiM(7) 46.5 2+  
CELAAAMKR seph(1) 49.98 2+  
CELAAAMKR seph(1) OxiM(7) 42.12 2+  
CGRIWAQVDTGKCR seph(1) 42.25 3+  
CKGTDVQAWIR seph(1) 54.45 2+ 3+  
DAFLGSFLYEYSR 90.88 1+ 2+  
DAFLGSFLYEYSRR 78.18 2+  
DAIPENLPPLTADFAEDK 57.32 3+  
DDAACCK seph(6) 51.45 2+  
DDPHACYSTVFDK seph(6) 56.65 2+ 3+  
DDPHACYSTVFDKLK 38 3+  
DGPLTGTYR 31.32 2+  
DGYVLSLNR 43.52 2+  
EACFAVEGPK seph(3) 57.8 2+  
ECCDKPLLEK seph(2) seph(3) 64.7 3+  
ECCHGDLLECADDR seph(10) 57.88 3+  
ECCHGDLLECADDR seph(2) 54.65 3+  
ECCHGDLLECADDR seph(3) 54.6 3+  
ECCHGDLLECADDR seph(3) 
seph(10) 60.03 3+  
ECGAHSEDAVCTK 56.5 3+  
EDLIAYLK 55.57 1+ 2+  
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EETLMEYLENPK 60.58 1+ 2+  
EETLMEYLENPK OxiM(5) 48.78 2+  
EETLMEYLENPKK 53.48 2+  
EETLMEYLENPKK OxiM(5) 44.92 2+  
ELTEPHGTFLR 48.85 3+  
EPISVSSQQMLK 41.43 2+  
EPISVSSQQMLK OxiM(10) 80.68 2+  
EYEATLEECCAK seph(9) seph(10) 48.82 3+  
FESNFNTQATNR 30.47 2+ 3+  
FLDDDLTDDIMCVK OxiM(11) 
seph(12) 67.25 2+  
FLDDDLTDDIMCVK seph(12) 71.1 2+  
GACLLPK seph(3) 57.08 2+  
GGKEVTHCQACK seph(11) 70.77 2+  
GTDVQAWIR 46.35 2+  
GTDVQAWIRGCRL seph(11) 71.73 2+ 3+  
GYSLGNWVCAAK seph(9) 70.07 1+ 2+  
HGTVVLTALGGILK 59.12 2+ 3+  
HGTVVLTALGGILKK 52.73 3+  
HKTAHSQALPK 59.15 3+  
HPEYAVSVLLR 48.62 2+  
HSLFCENR 50.25 2+  
IDALNENK 25.05 1+  
IDALNENKVLVLDTDYK 48.7 3+  
IETMREKVLASSAR 63.67 3+  
IFHESVYGQCK seph(10) 48.92 3+  
IFVQKCAQCHTVEK seph(6) 67.45 3+  
IFVQKCAQCHTVEK seph(9) 37.8 3+  
IGAFIMKTGPIYKK 46.42 3+  
ILDKVGINYWLAHK 51.93 3+  
IVSDGNGMNAWVAWR 56.82 2+  
KDGYVLSLNR 38.33 2+  
KILDKVGINYWLAHK 47.87 3+  
KIVSDGNGMNAWVAWR 55.85 3+  
KQACEGNEWK 29.97 2+  
KQTALVELLK 47.25 2+  
KVFGRCELAAAMK seph(6) 54.68 3+  
KVPQVSTPTLVEVSR 45.47 3+  
KYAAELHLVHWNTK 40.1 3+  
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LCVLHEK seph(2) 78.6 2+  
LDQWLCEK seph(6) 61.95 1+ 2+  
LGEYGFQNALIVR 55.07 2+  
LIVTQTMK OxiM(7) 26.22 2+  
LKECCDK seph(5) 55.48 2+  
LKECCDKPLLEK seph(4) seph(5) 63.95 2+ 3+  
LKPDPNTLCDEFK seph(9) 64.27 2+ 3+  
LRCASIQKFGER seph(3) 48.53 3+  
LSFNPTQLEEQCHI seph(12) 76.95 2+  
LSQKFPKAEFVEVTK 40.12 3+  
LVNELTEFAK 50.43 2+  
LVVSTQTALA 44.8 2+  
MPCTEDYLSLILNR 67.37 2+  
MPCTEDYLSLILNR OxiM(1) seph(3) 74.15 2+ 3+  
MPCTEDYLSLILNR seph(3) 77.87 2+ 3+  
NECFLSHK seph(3) 50.73 2+  
NECFLSHKDDSPDLPK seph(3) 52.1 3+  
NRCKGTDVQAWIR seph(3) 50.18 3+  
NRWAVWANMGNGDSVIK OxiM(9) 77.65 3+  
NTDGSTDYGILQINSR 45.9 2+ 3+  
PDPNTLCDEFK seph(7) 62.95 2+  
PLALVYGEATSR 44.43 2+  
QEPERNECFLSHK seph(8) 46.78 3+  
QNCDQFEK 47.43 2+  
QNCDQFEK seph(3) 45.37 2+  
QRLRCASIQK 37.32 3+  
RHPEYAVSVLLR 35.68 3+  
RPCFSALTPDETYVPK 65.57 2+  
RPCFSALTPDETYVPK seph(3) 59.85 2+ 3+  
SHCIAEVEK seph(3) 42.52 2+  
SLHTLFGDELCK seph(11) 69.77 2+ 3+  
TCVADESHAGCEK seph(2) seph(11) 49.33 2+ 3+  
TEREDLIAYLK 47.65 2+  
TGPNLHGLFGR 50.28 2+  
TGQAPGFTYTDANK 34.52 1+ 2+  
TGQAPGFTYTDANKNK 30.3 3+  
TVMENFVAFVDK 64.65 2+  
VEADIAGHGQEVLIR 40.07 3+  
VGDANPALQKVLDALDSIK 71.52 3+  
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VGINYWLAHK 47.87 2+  
VLDALDSIK 74.47 1+  
VLVLDTDYK 47.77 2+  
VPQVSTPTLVEVSR 46.4 3+  
VTKCCTESLVNRR 63.68 3+  
VTKCCTESLVNRR seph(4) 46.03 3+  
WWCNDGRTPGSR seph(3) 54.93 3+  
YAAELHLVHWNTK 45.78 3+  
YICDNQDTISSK seph(3) 52.72 2+  
YLEFISDAIIHVLHSK 72.88 2+ 3+  
YNGVFQECCQAEDK seph(8) 
seph(9) 76.98 2+  
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Table 2.9.  Non-cysteine peptides identified by UVPDnLossCID and the corresponding 
aromatic residues according to full database MassMatrix search. 
Non-Cys Full DB Residues # F/W/Y Residues 
AEFVEVTKLVTDLTK 1 
AIEYLYK 2 
ALPMHIR 0 
DAFLGSFLYEYSR 4 
DAFLGSFLYEYSRR 4 
DAIPENLPPLTADFAEDK 1 
DGPLTGTYR 1 
DGYVLSLNR 1 
EDLIAYLK 1 
EETLMEYLENPK 1 
EETLMEYLENPK OxiM(5) 1 
EETLMEYLENPKK 1 
EETLMEYLENPKK OxiM(5) 1 
ELTEPHGTFLR 1 
EPISVSSQQMLK 0 
EPISVSSQQMLK OxiM(10) 0 
FESNFNTQATNR 2 
GTDVQAWIR 1 
HGTVVLTALGGILK 0 
HGTVVLTALGGILKK 0 
HKTAHSQALPK 0 
HPEYAVSVLLR 1 
IDALNENK 0 
IDALNENKVLVLDTDYK 1 
IETMREKVLASSAR 0 
IGAFIMKTGPIYKK 2 
ILDKVGINYWLAHK 2 
IVSDGNGMNAWVAWR 2 
KDGYVLSLNR 1 
KILDKVGINYWLAHK 2 
KIVSDGNGMNAWVAWR 2 
KQTALVELLK 0 
KVPQVSTPTLVEVSR 0 
KYAAELHLVHWNTK 2 
LGEYGFQNALIVR 2 
LIVTQTMK OxiM(7) 0 
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LSQKFPKAEFVEVTK 2 
LVNELTEFAK 1 
LVVSTQTALA 0 
NRWAVWANMGNGDSVIK 
OxiM(9) 2 
NTDGSTDYGILQINSR 1 
PLALVYGEATSR 1 
RHPEYAVSVLLR 1 
RPCFSALTPDETYVPK 2 
TEREDLIAYLK 1 
TGPNLHGLFGR 1 
TGQAPGFTYTDANK 2 
TGQAPGFTYTDANKNK 2 
TVMENFVAFVDK 2 
VEADIAGHGQEVLIR 0 
VGDANPALQKVLDALDSIK 0 
VGINYWLAHK 2 
VLDALDSIK 0 
VLVLDTDYK 1 
VPQVSTPTLVEVSR 0 
YAAELHLVHWNTK 2 
YLEFISDAIIHVLHSK 2 
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